New search for studies and content updated (no change to conclusions)

Summary of findings {#CD001271-sec1-0001}
===================

Summary of findings for the main comparison**Nurse‐led primary care compared with doctor‐led primary care for patient outcomes, process of care and utilisationPatient or population:** all presenting patients in primary care\
**Settings:** UK (n = 6), Netherlands (n = 3), USA (n = 3), Canada (n = 3), Sweden (n = 1), Spain (n = 1), South Africa (n = 1)\
**Intervention:** substitution of doctors with nurses for primary care\
**Comparison:** routine doctor‐led primary care**OutcomesImpactNumber of participants (studies)Certainty of the evidence (GRADE)Illustrative comparative risks\* (95% CI)Effect estimate (95% CI)Results in wordsAssumed riskCorresponding riskDoctor‐led primary careNurse‐led primary careMortality**\
follow‐up:\
0.5 to 48 months\
Mean = 21 (SD 19) months**6.29 per 10004.84 per 1000**\
(4 to 6)**RR 0.77**\
(0.57 to 1.03)Nurse‐led primary care may lead to slightly fewer deaths among certain groups of patients, compared to doctor‐led care. However, the results vary and it is possible that nurse‐led primary care makes little or no difference to the number of deaths.36,529 (8)^1^⊕⊕⊝⊝ ^a^ **LowPatient health status**\
follow‐up:\
0.2 to 47 months\
Mean = 14 (SD 12) monthsCompared to doctor‐led care, nurse‐led primary care probably slightly improves blood pressure control; probably leads to similar outcomes for diabetes indicators and measures of disease activity and pain in people with rheumatological disorders; may lead to similar outcomes for physical functioning; and leads to similar outcomes for cholesterolClinical outcomes (3)\
Self‐reported measurements (13)^2^⊕⊕⊕⊝ ^b^ **ModerateSatisfaction and preferences**\
follow‐up:\
0.5 to 25 months\
Mean = 12 (SD 10) monthsPatient satisfaction is probably slightly higher in nurse‐led primary care compared to doctor‐led primary care.16,993 (7)^3^⊕⊕⊕⊝ ^c^ **ModerateQuality of life**\
follow‐up:\
6 to 25 months\
Mean = 15 (SD 9) monthsQuality of life may be slightly higher in nurse‐led primary care compared to doctor‐led primary care.16,002 (6)^4^⊕⊕⊝⊝^d^ **LowProcess of care**\
follow‐up:\
0.5 to 48 months\
Mean = 17 (SD 15) monthsWe are uncertain of the effects of nurse‐led care on process of care because the certainty of this evidence was assessed as very low.(10)^5^⊕⊝⊝⊝^e^\
**Very lowUtilisation (consultations, prescriptions, tests, investigations, and services)**\
follow‐up:\
0.2 to 48 months\
Mean = 14 (SD 13) months**Consultations:** Compared to doctor‐led primary care, consultation length is probably longer in nurse‐led primary care; there may be little or no difference in scheduled return visits; and the number of return visits attended is slightly higher for nurses.\
**Prescriptions, tests and investigations:** There is little or no difference between nurses and doctors in the number of prescriptions and may be little or no difference in the number of tests and investigations ordered.\
**Use of other services:** There may be little or no difference between nurses and doctors in the likelihood of hospital referrals and hospital admissions; little or no difference in attendance at accident and emergency units.(16)^6^⊕⊕⊕⊝ ^f^ **ModerateCosts**\
follow‐up:\
0.2 to 48 months\
Mean = 14 (SD 14) monthsWe are uncertain of the effects of nurse‐led care on the cost of care because the certainty of this evidence was assessed as very low.(9)^7^⊕⊝⊝⊝ ^g^ **Very low**\*The basis for the **assumed risk** is the mean control group risk across studies for pooled results. The **corresponding risk** is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). CI: confidence interval; RR: risk ratio; SD: standard deviation.\
^a^Downgraded by 1 for imprecision owing to a wide confidence interval that includes no effect and downgraded by 1 for clinical heterogeneity as the trials contributing to this estimate are quite varied (some focus on people with specific health issues and others on more generalist primary care attenders).\
^b^Downgraded by 1. Outcomes were downgraded by 1 for inconsistency, imprecision, indirectness or high risk of bias. The certainty of the evidence is moderate for all outcomes listed, apart for physical functioning for which the certainty of evidence was low and cholesterol for which the certainty of evidence was high.\
^c^Downgraded by 1 for inconsistency.\
^d^Downgraded by 1 for imprecision, due to a wide confidence interval that touches on the null, and 1 for inconsistency\
^e^Non‐comparable results and therefore downgraded to very low.\
^f^Downgraded by 1. Outcomes were downgraded by 1 for inconsistency, imprecision or high risk of bias.\
^g^Non‐comparable results (the types of costs assessed varied widely and a range of different approaches were used to value resources and calculate costs) and therefore downgraded to very low.\
^1^[@CD001271-bbs2-0001]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0014]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0018].\
^2^[@CD001271-bbs2-0001]; [@CD001271-bbs2-0002]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0014]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0018].\
^3^[@CD001271-bbs2-0001]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017].\
^4^[@CD001271-bbs2-0001]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013].\
^5^[@CD001271-bbs2-0001]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0018].\
^6^[@CD001271-bbs2-0001]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0018].\
^7^[@CD001271-bbs2-0001]; [@CD001271-bbs2-0002]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017].\
\*there may be additional data in the [@CD001271-bbs2-0001] articles that have not been extractedGRADE Working Group grades of evidence. **High certainty:** This research provides a very good indication of the likely effect. The likelihood that the effect will be substantially different^†^ is low. **Moderate certainty:** This research provides a good indication of the likely effect. The likelihood that the effect will be substantially different^†^ is moderate. **Low certainty:** This research provides some indication of the likely effect. However, the likelihood that it will be substantially different^†^ is high. **Very low certainty:** This research does not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different^†^ is very high\
^†^Substantially different = a large enough difference that it might affect a decision.

Background {#CD001271-sec1-0002}
==========

Description of the condition {#CD001271-sec2-0001}
----------------------------

A range of existing and anticipated issues, including ageing populations, increased prevalence of chronic conditions and multi‐morbidity, increased emphasis on healthy lifestyle and prevention, and movement of healthcare services from hospitals to communities, have encouraged countries worldwide to develop new models of primary care delivery ([@CD001271-bbs2-0038]; [@CD001271-bbs2-0071]). As many tasks do not necessarily require the knowledge and skills of a doctor, using nurses to expand the capacity of the primary care workforce is a topic of increasing interest ([@CD001271-bbs2-0052]; [@CD001271-bbs2-0055]). Substitution of nurses for doctors is one strategy for improving access to and efficiency and quality of care ([@CD001271-bbs2-0064]; [@CD001271-bbs2-0065]), and advanced nursing practice roles are common in high‐, middle‐ and low‐income countries ([@CD001271-bbs2-0052]; [@CD001271-bbs2-0055]). However, variation in primary care practice compositions is strong, and the same cadre might have different roles and authority in relation to practice depending on legislation, the healthcare system, and local practices ([@CD001271-bbs2-0038]; [@CD001271-bbs2-0041]; [@CD001271-bbs2-0054]). Furthermore, reforms currently being implemented in many countries regarding nurses' regulatory barriers or expansion of nurses' scope of practice (e.g. in relation to prescribing medicines) suggest a shift in the boundaries between medicine and nursing ([@CD001271-bbs2-0055]).

Description of the intervention {#CD001271-sec2-0002}
-------------------------------

Nurses in primary care may undertake many tasks traditionally performed by doctors. Tasks can be supplementary to those performed by doctors or can be substituted for doctors\' tasks. The current review focusses on tasks in which nurses *substitute* for doctors, meaning that they provide the same services as doctors ([@CD001271-bbs2-0054]; [@CD001271-bbs2-0068]), and is limited to care delivery for patients presenting with a physical complaint. These tasks may include diagnostics, treatment, referral to other services, health promotion, management of chronic diseases, or management of acute problems needing same‐day consultations. Contact with patients may take place in a primary health facility or in the home of the patient. Because people\'s understanding of what constitutes a nurse, as well as the educational levels of nurses, differs across countries ([@CD001271-bbs2-0052]; [@CD001271-bbs2-0055]), we have included in this review all registered nurses who provide care as substitutes for doctors. When available, we have provided information on the educational levels of nurses in the included studies, based on the European Qualification Framework ([@CD001271-bbs2-0036]). Moreover, the review aimed to include studies from high‐, middle‐, and low‐income countries, and we have described the impact of this approach on heterogeneity.

How the intervention might work {#CD001271-sec2-0003}
-------------------------------

The expectation is that nurses substituted for doctors can do the following (e.g. [@CD001271-bbs2-0038]; [@CD001271-bbs2-0052]; [@CD001271-bbs2-0063]; [@CD001271-bbs2-0068]).

Enhance the quality of services provided in primary care.Increase access to primary care services, as capacity increases.Reduce doctors\' workload and thus free up time for doctors to take up more complex tasks.Reduce costs of care through lower salary costs for nurses and limited educational training, which is provided more quickly and is less expensive.

This last point was not, however, confirmed by a previous systematic review on this intervention ([@CD001271-bbs2-0061]). Gains in service efficiency may be achieved if doctors no longer provide the services they have delegated to nurses. This enables doctors to focus on complexity in their caseload and on utilising their advanced training and experience ([@CD001271-bbs2-0031]; [@CD001271-bbs2-0070]).

Why it is important to do this review {#CD001271-sec2-0004}
-------------------------------------

Advanced nursing practice roles have been developed worldwide, including in low‐, middle‐, and high‐income countries ([@CD001271-bbs2-0038]; [@CD001271-bbs2-0052]; [@CD001271-bbs2-0055]). The first advanced nursing roles were developed in the USA and Canada in the late 1960s/70s, in the UK in the 1980s, and in other high‐income countries in the 1990s and onwards ([@CD001271-bbs2-0054]). From the outset, nurses have been utilised to deliver primary care, traditionally in underserved areas and to vulnerable populations. Nowadays, their role has been extended to include other types of services in primary care ([@CD001271-bbs2-0067]), and this change has been implemented in a range of countries around the globe ([@CD001271-bbs2-0038]; [@CD001271-bbs2-0052]; [@CD001271-bbs2-0055]).

Nurses in advanced roles represent a substantial source of human capital to increase quality of care, access to (primary) care, and, as it is sometimes argued, efficiency of care, although recent reviews have not confirmed improvements in efficiency ([@CD001271-bbs2-0057]; [@CD001271-bbs2-0058]; [@CD001271-bbs2-0059]; [@CD001271-bbs2-0060]; [@CD001271-bbs2-0061]). It is believed that inclusion of nurses in advanced roles can ensure that the demand for healthcare services to address patient needs is properly met. Both practitioners and policy makers believe that to meet the challenges faced by primary care, a more robust healthcare workforce, including both doctors and nurses in advanced nursing roles, is needed ([@CD001271-bbs2-0064]).

Although interest in expanding nursing roles and employing nurses as substitutes for doctors is increasing globally, underlying reasons for these initiatives differ depending on local context and circumstances ([@CD001271-bbs2-0073]). For example, the Health Resources and Services Administration in the USA, anticipating a shortage of doctors, has increased the amount of money available not only to train doctors but also to prepare nurse practitioners and physician assistants to support the primary care workforce ([@CD001271-bbs2-0066]). In addition, organisations such as the World Health Organization (WHO) have made several recommendations regarding ways to expand the role of nurses ([@CD001271-bbs2-0075]). To enable policy makers to make informed decisions about healthcare delivery models, we need rigorous evidence on the quality of care, as well as on access and costs, associated with care provided by nurses compared with care provided by doctors.

Since this review was first published in 2005 ([@CD001271-bbs2-0079]), a large number of comparative studies have produced a stronger evidence base with regard to the effectiveness of nurse‐doctor substitution. Many new studies on nurses in primary care show increasing international interest in task shifting and in shifting of boundaries between medicine and nursing. Moreover, regulatory and educational reforms internationally support the trend towards advanced nursing roles in healthcare delivery and task shifting. The growth rate of the nursing workforce is now three times that of the workforce for doctors (nine times that for nurse practitioners), which provides an important opportunity to meet increasing demand within primary care ([@CD001271-bbs2-0055]).

This updated review adds value to recently published systematic reviews on this topic by excluding studies that do not focus solely on substitution, resulting in more accurate findings regarding the effectiveness of nurse‐doctor substitution specifically; and by using rigorous Cochrane methods. Additional insights provided by this update are important because results reported by some other reviews have been inconclusive (e.g. on costs), and because the ways in which primary healthcare services are organised have changed since our original review was published.

Objectives {#CD001271-sec1-0003}
==========

Our aim was to investigate the impact of nurses working as *substitutes* for primary care doctors on:

patient outcomes;processes of care; andutilisation, including volume and costs.

Methods {#CD001271-sec1-0004}
=======

Criteria for considering studies for this review {#CD001271-sec2-0005}
------------------------------------------------

### Types of studies {#CD001271-sec3-0001}

Randomised trials (i.e. trials with random allocation of participants to intervention and control groups). We included controlled before‐after studies and non‐randomised trials in our previous Cochrane review ([@CD001271-bbs2-0079]). The number of available randomised trials has increased since that time; therefore, we decided to exclude controlled before‐after studies (n = 3) and non‐randomised trials (n = 3) from this update. Randomised trials provide more robust evidence on effectiveness, and including other study designs is unlikely to be worthwhile in light of the many randomised trials now available.

### Types of participants {#CD001271-sec3-0002}

*Doctors:* any kinds of doctors working in a primary care setting, including general practitioners, family doctors, paediatricians, general internists, and geriatricians. In this review, we use \'doctor\' as the generic term for this cadre.*Nurses:* any qualified registered nurses working as substitutes for doctors in primary care. The definition of a qualified nurse is "a graduate who has been legally authorised (registered) to practice after examination by a state board of nurse examiners or similar regulatory authority" [(]{.ul}[@CD001271-bbs2-0075][)]{.ul}. Included are nurse practitioners, clinical nurse specialists, advanced practice nurses, practice nurses, health visitors, etc. As the job title, education, and experience of nurses vary considerably among and within countries, we did not select nurses by virtue of their job title. We excluded only mental health nurses as this kind of substitution is addressed by the EPOC review on non‐specialist health workers for mental health ([@CD001271-bbs2-0039]). We also excluded trainee nurses as they do not work to their full potential as a consequence of their traineeship.*Patients:* any persons presenting in primary care with a physical complaint.

This review is limited to primary healthcare services that provide first contact and ongoing care for patients with all types of physical health problems. It includes family practice, general practice, out‐patient care, and ambulatory primary care settings but excludes accident and emergency departments in hospitals. Patients presenting to accident and emergency departments in hospitals are not considered to be comparable to patients presenting for primary care services. These hospital departments generally deal with genuine life‐threatening emergencies and therefore are not considered an alternative to an appointment with a doctor in primary care.

### Types of interventions {#CD001271-sec3-0003}

This review focusses on nurses working as substitutes for primary care doctors. Substitution refers to the situation wherein task(s) formerly performed by one type of professional (i.e. a doctor) are transferred to a different type of professional (i.e. a nurse), usually with the intention of reducing cost or addressing workforce shortages ([@CD001271-bbs2-0038]; [@CD001271-bbs2-0054]). Substitution studies typically examine cases in which a nurse is responsible for providing the same health care as a doctor and compare the performance of these two practitioners. For example, study authors may compare a nurse‐led clinic for a particular disease or condition versus a doctor‐led clinic for that same disease or condition.

We excluded studies which evaluated nurses supplementing the work of primary care doctors. Supplementation refers to the situation wherein a nurse supplements or extends the care provided by a doctor by providing a new primary care service. Generally, the aim is to improve the quality of care rather than reduce cost or address workforce shortages. Supplementation studies typically compare usual care provided by a doctor versus an innovative service provided by a nurse working alongside a doctor. For example, researchers may compare a family practice with a nurse‐led diabetes clinic versus a family practice without such a clinic. This type of study risks confounding two aspects of care provision: type of service (specialised clinic vs routine consultation), and who provides that service (doctor or nurse).

### Types of outcome measures {#CD001271-sec3-0004}

We considered three types of outcomes for inclusion in this review: patient outcomes; process of care outcomes; and utilisation outcomes, including both volume and costs.

#### Primary outcomes {#CD001271-sec4-0001}

##### Patient outcomes {#CD001271-sec5-0001}

MortalityHealth status (clinical outcomes and self‐reported outcomes)SatisfactionQuality of lifeOther (compliance, knowledge, preference for doctor or nurse)

#### Secondary outcomes {#CD001271-sec4-0002}

##### Process of care outcomes {#CD001271-sec5-0002}

Practitioner adherence to clinical guidelinesPractitioner healthcare activity (examinations, provision of advice)

##### Utilisation outcomes {#CD001271-sec5-0003}

###### Volume {#CD001271-sec6-0001}

Frequency and length of consultationsNumber of return visitsNumber of prescriptionsNumbers of tests and investigationsNumber of referrals to or frequency of use of other services

###### Costs {#CD001271-sec6-0002}

Direct health service costs related to volumeIndirect (societal) costs

Search methods for identification of studies {#CD001271-sec2-0006}
--------------------------------------------

### Electronic searches {#CD001271-sec3-0005}

We searched the following databases.

Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 12), part of the Cochrane Library ([www.cochranelibrary.com](www.cochranelibrary.com) (searched 20.01.2015).MEDLINE In‐Process & Other Non‐Indexed Citations, MEDLINE Daily, MEDLINE and Ovid OLDMEDLINE 1946 to present, Ovid (searched 20.01.2015).Cumulative Index to Nursing and Allied Health Literature (CINAHL) 1981 to present, EbscoHost (searched 20.01.2015).

We performed an updated search in CENTRAL, MEDLINE, and CINAHL in March 2017. We have added one study to 'Studies awaiting classification' and will incorporate this study into the review at the next update.

### Searching other resources {#CD001271-sec3-0006}

#### Grey literature databases {#CD001271-sec4-0003}

The Grey Literature Report ([http://www.nyam.org/library/online‐resources/grey‐literature‐report/](http://www.nyam.org/library/online‐resources/grey‐literature‐report/)) (searched 21.02.2017)OpenGrey (<http://www.opengrey.eu/>) (searched 21.02.2017)

#### Trial registries {#CD001271-sec4-0004}

International Clinical Trials Registry Platform (ICTRP), World Health Organization (WHO) (<http://www.who.int/ictrp/en/>) (searched 21.02.2017)ClinicalTrials.gov, US National Institutes of Health (NIH) (<http://clinicaltrials.gov/>) (searched 21.02.2017)

We also searched the Science Citation Index and the Social Sciences Citation Index 1975 to present, for articles citing relevant studies, as well as Web of Knowledge (Thomson Reuters) (searched 27.01.2015) and the reference lists of all included papers and identified relevant reviews.

Please see [Appendix 1](#CD001271-sec2-0016){ref-type="app"} for strategies used and the PRISMA flow chart ([Figure 1](#CD001271-fig-0001){ref-type="fig"}) for records retrieved, excluded, and included.Figure 1Study flow diagram.

Data collection and analysis {#CD001271-sec2-0007}
----------------------------

### Selection of studies {#CD001271-sec3-0007}

At least two review authors (among ML, NW, KW, EK, and AVV) independently screened search results at three levels: titles; abstracts to assess which studies potentially satisfied the inclusion criteria; and full‐text copies of papers that were potentially relevant. If we could not assess the paper for eligibility based on title or abstract, we obtained the full text. Where data was published in duplicate, we included these data only once in the review.

### Data extraction and management {#CD001271-sec3-0008}

For this review, we designed a data extraction form that was based on the previously used standard form of the Cochrane Effective Practice and Organisation of Care Group (EPOC). At least two review authors (of ML, MB, NW, KW, EK, and AVV) independently abstracted data from each study and resolved differences by discussion.

If a single publication reported two or more separate studies, we extracted each study separately. If findings of a single study were spread across two or more publications, we extracted data from these publications as one. We extracted outcomes measured at different time points and presented in different publications, for example, at six months and two years after the intervention. We used the longest follow‐up in meta‐analyses. For each study with more than one control or comparison group for the nurse intervention, we reported only results for the control condition in which doctors provided the same intervention as the nurse.

### Assessment of risk of bias in included studies {#CD001271-sec3-0009}

At least two review authors (among ML, MB, NW, KW, EK, and AVV) independently assessed risk of bias of each included study using the criteria suggested by EPOC ([@CD001271-bbs2-0035]). We assessed randomised trials for generation of allocation sequence, concealment of allocation, similar baseline outcome measurements, similar baseline characteristics, incomplete outcome data, blinding of participants, blinding of outcome assessors, protection against contamination, selective outcome reporting, and bias due to lack of power. We scored each study for risk of bias as follows: 'low' if all key domains were scored as 'low risk'; 'unclear' if one or two key domains were scored as 'unclear risk'; and 'high' if more than two key domains were scored 'unclear risk' or 'high risk'. When no information was available, we scored \'unclear risk\'. For similar baseline characteristics and outcome measurements, we scored \'low risk\' when baseline values were equal, or when analysis included a correction for differences in baseline values. We scored incomplete outcome data as low risk when follow‐up was ≥ 80% or when follow‐up was \< 80%, with equal results attained by intention‐to‐treat (ITT) and per‐protocol (PP) analyses. With respect to blinding, we used the following approach. When investigators reported no blinding of patients and personnel, we scored \'unclear risk\', because we do not know whether lack of blinding influenced study results. For some objective outcomes (e.g. mortality), blinding does not influence risk of bias, but for other outcomes in the same study (e.g. satisfaction), non‐blinding may influence outcomes.

We did not split the different outcomes for assessment of risk of bias within a study because the judgement of risk of bias was generally equal for all outcomes within a study. If the risk of bias judgement for a particular outcome was divergent, we commented on that.

We have shown assessments of risk of bias for included studies in the [Characteristics of included studies](#CD001271-sec2-0020){ref-type="sec"} table and have summarised this information in [Figure 1](#CD001271-fig-0001){ref-type="fig"} and [Figure 2](#CD001271-fig-0002){ref-type="fig"}. We did not use risk of bias assessments in deciding which studies should be included in the meta‐analyses. However, we conducted sensitivity analyses by excluding studies with high risk of bias (see [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}). Furthermore, we used these assessments in interpreting study results and, particularly, in assessing the certainty of evidence for nurse‐doctor substitution.Figure 2Risk of bias graph: review authors\' judgements about each risk of bias item presented as percentages across all included studies.

### Measures of treatment effect {#CD001271-sec3-0010}

The measure of effect size for continuous outcomes (patient satisfaction, disease activity score, pain, and length of consultation) was the standardised mean difference (SMD)*.* The SMD is more appropriate than the mean difference (MD) in situations where the measurement instrument (i.e. the patient satisfaction scale) differs between studies. (See the *Cochrane Handbook for Systematic Reviews of Interventions* version 5.1.0.) We used MDs for patient outcomes including blood pressure, cholesterol, and glycated haemoglobin (HbA1c).

The measure of effect size used for dichotomous outcomes was the risk ratio (RR). (See the *Cochrane Handbook for Systematic Reviews of Interventions* version 5.1.0.) We converted odds ratios (ORs) to RRs using the built‐in calculator in RevMan 5.3 ([@CD001271-bbs2-0069]).

### Unit of analysis issues {#CD001271-sec3-0011}

We included in the meta‐analyses three cluster‐randomised trials along with fifteen individually randomised trials. We included one cluster‐randomised trial that accounted for clustering in their analyses ([@CD001271-bbs2-0001]). Two of the included cluster‐randomised trials did not correct adequately for clustering ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0016]). We explored the impacts of these trials by performing a [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}.

### Dealing with missing data {#CD001271-sec3-0012}

For missing or unclear information, we contacted study investigators to request clarification or additional information. For studies that reported continuous data but did not report standard deviations, we calculated these values from other available data such as standard errors, or imputed them using the methods suggested in [@CD001271-bbs2-0043].

We extracted data from the ITT analysis when possible. If ITT data were not present, we excluded the study from meta‐analyses by performing a [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}.

### Assessment of heterogeneity {#CD001271-sec3-0013}

#### Clinical settings, country contexts, and methodological diversity {#CD001271-sec4-0005}

We first made a qualitative assessment of the extent to which studies assessing a particular comparison were similar to one another. This included assessment of clinical settings, country contexts, and types of measurement scales to determine whether meta‐analysis was appropriate.

#### Statistical heterogeneity {#CD001271-sec4-0006}

We obtained an initial visual overview of statistical heterogeneity by scrutinising forest plots, looking at the overlap between confidence intervals around the estimate for each included study. In addition, we used the I^2^ statistic and confidence intervals to estimate and quantify heterogeneity.

### Assessment of reporting biases {#CD001271-sec3-0014}

To reduce possible publication bias, we employed strategies to search for and identify relevant unpublished studies for inclusion. These strategies included searching the grey literature and prospective trial registration databases to overcome time‐lag bias.

We used funnel plots for outcomes reported by more than four studies to visualise whether data showed asymmetry. No plots showed asymmetry. However, we identified too few studies for reliable assessment of funnel plot asymmetry ‐ visually or quantitatively.

### Data synthesis {#CD001271-sec3-0015}

To summarise the effectiveness of the nurse‐doctor substitution, we performed several meta‐analyses. We conducted statistical meta‐analyses using the RevMan 5.3 software distributed by Cochrane ([@CD001271-bbs2-0069]). For studies in which quantitative data were absent or were insufficient for calculation, we reproduced the data as presented in the additional tables, undertook a structured synthesis, and reported the findings narratively. We performed a meta‐analysis if the nature of the outcome and other key aspects of studies were similar. We used adjusted RRs if available in the article. When not available, we calculated RRs from events. For categorical outcomes, we calculated log RRs and standard errors (SEs) of log RRs for both individual and cluster‐randomised trials. We analysed together log RRs for individual randomised trials and adjusted log RRs for cluster‐randomised trials. We preferred RRs over ORs because interpretation is intuitive. When no cluster‐randomised trials were included in the meta analysis, we used RRs instead of log RRs.

We used a random‐effects meta‐analysis, which is known to be more conservative and more suitable in the presence of any heterogeneity ([@CD001271-bbs2-0050]). Although we expected substantial heterogeneity in some cases, which could be attributed to differences among populations, interventions, comparators, outcomes, and settings, we are aware that detection of existing heterogeneity can be problematic for meta‐analysis that includes a small number of studies ([@CD001271-bbs2-0051]). Therefore, for greater transparency, we reported 95% confidence intervals of the I^2^ statistic, obtained under an inverse variance DerSimonian‐Laird random‐effects model for continuous outcomes, and a Mantel‐Haenszel/DerSimonian‐Laird random‐effects model hybrid for dichotomous outcomes.

#### \'Summary of findings\' {#CD001271-sec4-0007}

We used the GRADE approach to assess the certainty of evidence related to each of the key outcomes ([Schünemann 2009](Schünemann 2009)). We used the GRADE profiler to import data from Review Manager 5.3 and create [Table 1](#CD001271-tbl-0001){ref-type="table"} ([@CD001271-bbs2-0069]; [@CD001271-bbs2-0040]).

For assessments of the overall certainty of evidence for each outcome, we downgraded the evidence from \'high certainty\' by one level for serious (or by two levels for very serious) study limitations (risk of bias), indirectness of evidence, serious inconsistency, imprecision of effect estimates, or potential publication bias. We provided justification for decisions to downgrade or upgrade ratings by inserting footnotes into the table and made comments to aid readers\' understanding of the review when necessary. We used plain language statements to report these findings in the review.

We used these assessments, along with evidence for absolute benefit or harm of the interventions and the sum of available data on all critical and important outcomes from each study included for each comparison, to draw conclusions about the effectiveness of nurse‐led primary care. [Table 1](#CD001271-tbl-0001){ref-type="table"} consists of critically important clinical and functional outcomes identified in the selected trials.

When judging the importance of SMDs, we acknowledged that 0.2 represents a slight effect, 0.5 a moderate effect, and 0.8 a significant effect ([Guyatt 2008](Guyatt 2008); [Higgins 2011](Higgins 2011)).

### Subgroup analysis and investigation of heterogeneity {#CD001271-sec3-0016}

During the review process, we identified several factors that might explain heterogeneity in review findings, including type of nurse (i.e. nurse, registered nurse, nurse practitioner, specialised nurse); characteristics of the intervention and the comparator (i.e. total substitution, partial substitution); study size; duration of follow‐up; type of care (i.e. single contact, series, urgent care); range of patient complaints (i.e. all patients or particular patient groups); and setting. We undertook these as exploratory, hypothesis‐generating analyses because these factors were not identified a priori and several potentially explanatory factors were considered. We considered undertaking a subgroup analysis based on nurse title as described in the included studies, as has been done in other systematic reviews ([@CD001271-bbs2-0057]). However, we have little information about exact role definitions and educational levels of nurses in the different trials, and we know that job titles differ among countries; therefore, we decided it was not possible to create clear and valid subgroups for subgroup analyses.

### Sensitivity analysis {#CD001271-sec3-0017}

We performed sensitivity analyses by excluding trials assessed as having high risk of bias (overall) ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0012]), cluster‐randomised trials ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0016]), trials presenting per‐protocol (PP) rather than intention‐to‐treat (ITT) data when follow‐up was \< 80% ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0017]), trials from low‐income countries ([@CD001271-bbs2-0014]), and trials in which investigators had calculated the RR from an OR ([@CD001271-bbs2-0007]). We performed all sensitivity analyses on all outcomes.

Results {#CD001271-sec1-0005}
=======

Description of studies {#CD001271-sec2-0008}
----------------------

### Results of the search {#CD001271-sec3-0018}

We identified a total of 4831 articles from electronic and supplementary searches. We excluded 4741 articles following a review of titles and abstracts and retrieved and assessed the full text of 90 articles. We excluded 78 full‐text articles that investigated the role of nurses working as supplements to primary care doctors and excluded two additional studies that involved a mix of primary and hospital care. Nine randomised trials met the inclusion criteria, and we included them in this update. We performed an updated search in CENTRAL, MEDLINE, and CINAHL in March 2017. We have added one study to 'Studies awaiting classification' and will incorporate this study into the review at the next update. We have presented the study flow diagram in [Figure 1](#CD001271-fig-0001){ref-type="fig"}.

### Included studies {#CD001271-sec3-0019}

We included nine new randomised trials in this update ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0014]; [@CD001271-bbs2-0018]). The review now includes 18 randomised trials in which nurses worked as substitutes for doctors. Four of them were cluster‐randomised trials ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0002]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0016]) that were randomised by practice ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0011]) or by family ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0016]). We described the findings of the included studies below and summarised them in the [Characteristics of included studies](#CD001271-sec2-0020){ref-type="sec"} table.

#### Setting {#CD001271-sec4-0008}

Six studies were conducted in the UK ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0015]), three in the Netherlands ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0018]), three in the USA ([@CD001271-bbs2-0005]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0012]), three in Canada ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]), one in Sweden ([@CD001271-bbs2-0008]), one in Spain ([@CD001271-bbs2-0007]), and one in South Africa ([@CD001271-bbs2-0014]).

Nurses substituted for doctors in a range of care settings. Interventions were carried out in general practices/family practices ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0002]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0014]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0018]),(out‐patient) nurse clinics ([@CD001271-bbs2-0003]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0013]). and specialised practices ([@CD001271-bbs2-0005]).

The study period ranged from 2 weeks in [@CD001271-bbs2-0017] to 48 months ([@CD001271-bbs2-0013]) with a mean of 14 months (standard deviation (SD) 12 months). For one study, the study period remains unknown ([@CD001271-bbs2-0006]).

#### Role of the nurse {#CD001271-sec4-0009}

Included studies were of nurse‐doctor substitution in primary care for provision of first contact care (including urgent care), ongoing care for all presenting physical complaints, and follow‐up of patients with a particular chronic condition. Nurse‐doctor substitution for preventive services and health education in primary care has been less well studied.

In five studies, the nurse assumed responsibility for first contact and ongoing care for all presenting patients ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0016]).In five studies, the nurse assumed responsibility for first contact care for patients wanting (urgent) consultations during routine practice hours ‐ [@CD001271-bbs2-0001]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017] ‐ or out‐of‐hours ‐ [@CD001271-bbs2-0009].In seven studies, the nurse had responsibility for ongoing treatment or follow‐up of patients with a particular chronic disease ([@CD001271-bbs2-0003]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0014]).In one study, the nurse provided mainly health education or preventive services to a specific group of patients ([@CD001271-bbs2-0018]).

### Excluded studies {#CD001271-sec3-0020}

We excluded almost all excluded full‐text articles because they investigated the role of nurses working as supplements to primary care doctors. We excluded seven studies from this update that had been included in the previous version of the review ([@CD001271-bbs2-0079]): one study focussed on mental health problems ([@CD001271-bbs2-0025]); three controlled before‐after studies ‐ [@CD001271-bbs2-0019]; [@CD001271-bbs2-0021]; [@CD001271-bbs2-0026]; and three non‐randomised studies ‐ [@CD001271-bbs2-0020]; [@CD001271-bbs2-0023]; [@CD001271-bbs2-0027] . In addition, we excluded two studies that involved a mix of primary care and hospital care ([@CD001271-bbs2-0024]; [@CD001271-bbs2-0022]). We listed these nine studies in the [Characteristics of excluded studies](#CD001271-sec2-0021){ref-type="sec"} tables.

Risk of bias in included studies {#CD001271-sec2-0009}
--------------------------------

We prepared an assessment of risk of bias for each trial and illustrated final judgements for the ten criteria in [Figure 2](#CD001271-fig-0002){ref-type="fig"} and [Figure 3](#CD001271-fig-0003){ref-type="fig"}. All studies had some methodological shortcomings, in most instances related to unclear risk of bias for different criteria. We judged only one study to be at high risk of bias for more than one criterion ([@CD001271-bbs2-0012]). The criteria most commonly assessed as having unclear risk of bias were blinding of personnel, outcome assessment, and selective reporting. The criterion most commonly assessed as having high risk of bias was contamination ([@CD001271-bbs2-0010]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0018]).Figure 3Risk of bias summary: review authors\' judgements about each risk of bias item for each included study.

### Allocation {#CD001271-sec3-0021}

Most studies stated that participants or practices (in case of cluster randomisation ([@CD001271-bbs2-0001])) were assigned randomly, according to a computerised randomisation scheme. Twelve of the included studies met the 'low risk of bias' criteria for random sequence generation. Most of these studies used a computer ([@CD001271-bbs2-0003]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0018]), and some used envelopes for this purpose ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0015]). For six studies, the risk of bias for random sequence generation was unclear owing to poor reporting. [@CD001271-bbs2-0001] used a random component in the sequence process, and 10 of 15 practices withdrew after randomisation, which made the risk of bias unclear.

#### Baseline values {#CD001271-sec4-0010}

Most studies provided similar outcome measurements between the two study arms at baseline or corrected for differences in baseline values. [@CD001271-bbs2-0005] did not assess baseline characteristics, and study arms differed for one or two outcome measures in [@CD001271-bbs2-0008].

### Blinding {#CD001271-sec3-0022}

Risk of performance bias was low in two studies ([@CD001271-bbs2-0005]; [@CD001271-bbs2-0018]). In [@CD001271-bbs2-0005], personnel did not know which patients were included in the study, and [@CD001271-bbs2-0018] collected data retrospectively and asked patients for their consent after one year. For all other studies, we judged the risk of performance bias as unclear because no information was available. We expect that patients and personnel were not blinded in these studies because the care provider constitutes the intervention. Whether this lack of blinding influences outcomes is unclear. Three studies satisfied the criteria for blinding of outcome assessors ([@CD001271-bbs2-0003]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0013]). These studies provided independent researchers who where blind to group assignment when measuring outcomes. Most studies did not provide sufficient information on blinding of outcome assessment; we therefore assessed them as having unclear risk of detection bias.

### Incomplete outcome data {#CD001271-sec3-0023}

Three studies reported follow‐up less than 80% ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0017]); we therefore judged these studies to have high risk of bias for incomplete outcome data. In most studies, 80% or more of the initial participants completed the study. Risk of bias due to incomplete outcome data was unclear in [@CD001271-bbs2-0005] because of limited reporting about follow‐up. [@CD001271-bbs2-0013] reported follow‐up of less than 80%. However, investigators performed both ITT and PP analyses and reported the same results ([@CD001271-bbs2-0013]).

### Selective reporting {#CD001271-sec3-0024}

We judged two studies to have low risk for selective outcome reporting bias ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0013]). A protocol was available for each study, and these papers reported predefined outcome measures. Absence of study protocols to confirm reporting of all intended outcomes led to the unclear judgement in all other studies.

### Other potential sources of bias {#CD001271-sec3-0025}

Risk of bias due to contamination was high in four studies ([@CD001271-bbs2-0010]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0018]). These studies reported an increased likelihood of cross‐over of patients or personnel between groups. Contamination was not likely in six studies ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0014]). Lack of information or insufficient details in the paper led to judgement of unclear risk in the other studies.

Effects of interventions {#CD001271-sec2-0010}
------------------------

See: [Table 1](#CD001271-tbl-0001){ref-type="table"}

### Patient outcomes {#CD001271-sec3-0026}

A total of 18 trials investigated patient outcomes ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0002]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0014]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0018]) ([Table 3](#CD001271-tbl-0003){ref-type="table"}).Table 1Patient outcome: health status**StudyVarious health status outcomes**[@CD001271-bbs2-0002][Health status:]{.ul}\
‐ Emotional function: no difference^a^\
‐ Social function: no difference^a^[@CD001271-bbs2-0003][Health status:]{.ul}\
‐ Severity of symptoms: Nurse group had greatest improvement. Difference adjusted for baseline 2.3 (95% CI 1.4 to 3.1), P \< 0.001[@CD001271-bbs2-0004][Health status:]{.ul}\
‐ Burden of illness: nurse vs doctor (MD 0.27, P = 0.16)\
‐ Concerns about illness: nurse vs doctor (MD 0.11, P = 0.20)\
‐ Absence of work: both nurse and doctor 1.11 days^a,b^\
‐ Ability to perform daily activities: nurse mean 2.53, doctor mean 2.69^a,b^[@CD001271-bbs2-0006][Objective measures of patient health]{.ul} (MD (95% CI))[:]{.ul}\
‐ BMI (kg/m^2^): nurse ‐0.2 (‐0.5; 0.1), doctor ‐0.3 (‐0.6; ‐0.1), P = 0.377\
‐ Cholesterol/HDL: nurse ‐0.03 (‐0.1; 0.2), doctor ‐0.07 (‐0.1; ‐0.2), P = 0.321\
[Health status:]{.ul}\
‐ Diabetes symptom score: no difference^a,b^\
‐ Fatigue: no difference^a,b^\
‐ Cognitive distress: no difference^a,b^[@CD001271-bbs2-0008][Health status:]{.ul}\
‐ DAS28‐CRP: nurse vs doctor 0.05 (95% CI ‐0.28 to 0.19, P = 0.70)\
‐ ESR (mm/h): nurse vs doctor ‐1.05 (95% CI ‐3.97 to 1.86, P = 0.47)\
‐ CRP (mg/L): nurse vs doctor ‐1.07 (95% CI ‐2.02 to ‐0.12, P = 0.03)\
‐ Swollen joints (28): nurse vs doctor 0.13 (95% CI ‐2.18 to 0.61, P = 0.60)\
‐ Tender joints (28): nurse vs doctor 0.33 (95% CI ‐0.47 to 1.13, P = 0.42)\
‐ VAS global health (mm): nurse vs doctor 4.29 (95% CI ‐2.58 to 11.16, P = 0.22)[@CD001271-bbs2-0010][Health status:]{.ul}\
‐ Resolution of symptoms in nurse group from 16.33 to 18.39 (possible range 6 to 24; higher scores mean fewer reductions in complaints). Doctors no change. P \< 0.02[@CD001271-bbs2-0011][Health status (lifestyle factor)]{.ul}:\
‐ Smoking: no difference^a^\
‐ Blood pressure (mmHg) systolic: nurse 148 (142 to 153), GP 147 (135 to 153), P = 0.82^a^\
‐ Blood pressure (mmHg) diastolic: nurse 80 (74 to 87), GP 81 (75 to 83), P = 0.82^a^\
‐ Cholesterol (mmol/L) total: nurse 5.4 (5.2 to 5.5), GP 5.5 (5.0 to 5.9), P = 0.61^a^\
‐ Cholesterol (mmol/L) high‐density lipoprotein: nurse 1.2 (1.1 to 1.3), GP 1.2 (1.2 to 1.3), P = 0.83^a^[@CD001271-bbs2-0012][Health status (10 dimensions)]{.ul}: no difference^b^\
[Objective measures of patient health:]{.ul}\
‐ Asthma ‐ peak flow: NP 292.82 (94.2), GP 319.90 (136.56), P = 0.365[@CD001271-bbs2-0013][Health status:]{.ul}\
‐ Fatigue ITT: nurse \< doctor; mean (95% CI) 3.38 (‐2.01 to 8.76), P = 0.0171\
‐ Stiffness ITT: nurse \< doctor; mean (95% CI) 8.91 (‐2.66 to 20.5), P = 0.0113\
‐ RAQoL ITT: nurse \< doctor; mean (95% CI) ‐0.14 (‐1.77 to 1.49), P = 0.0001\
‐ HAQ ITT: nurse \> doctor; mean (95% CI) ‐0.07 (‐0.21 to 0.07), P \< 0.0001\
‐ HAD‐Anxiety ITT: nurse \< doctor; mean (95% CI) 0.54 (‐0.36 to 1.43), P = 0.0179\
‐ HAD‐Depression ITT: nurse \< doctor; mean (95% CI) 0.12 (‐0.65 to 0.89), P = 0.0004\
‐ ASES ITT: nurse \> doctor; mean (95% CI) ‐0.92 (‐4.96 to 3.12), P = 0.0019[@CD001271-bbs2-0014][Health status:]{.ul}\
‐ Cumulative failure: nurse 48%, doctor 44% HR (95% CI) 1.09 (0.89 to 1.33)\
‐ All virological failure: nurse 11%, doctor 10% HR (95% CI) 1.15 (0.75 to 1.76)\
‐ Toxicity failure: nurse 17%, doctor 16% HR (95% CI) 1.04 (0.74 to 1.45)\
‐ Death: nurse 3%, doctor 3% HR (95% CI) 0.92 (0.39 to 2.17)[@CD001271-bbs2-0016][Health status:]{.ul}\
‐ Physical function (3 indicators): nurses 86%, doctors 88%^b^\
‐ Emotional function: nurses 58%, doctors 58%^b^\
‐ Social function: nurses 84%, doctors 83%^b^[@CD001271-bbs2-0017][Health status:]{.ul} no difference^a^[@CD001271-bbs2-0018][Objective measures of patient health:]{.ul}\
‐ LDL cholesterol: nurse 2.9, doctors 3.0, P = 0.07\
‐ BMI: nurse 27.2, doctor 27.2, P = 0.87\
[Health status (lifestyle factor):]{.ul}\
‐ Smoking: 4% of smokers in the GP group (4/102) and 6% in the practice nurse group (4/67)^b^\
*[Subgroup: at‐risk patients]{.ul}*\
‐ Systolic blood pressure: nurse 144.0, doctor 147.6, P = 0.1\
‐ Total cholesterol: nurse 5.2, doctor 5.6, P = 0.006\
‐ LDL cholesterol: nurse 3.1, doctor 3.3, P = 0.16\
‐ BMI: nurse 28.6, doctor 28.6, P = 0.78[^2]

We have grouped patient outcomes into the following categories: mortality, health status outcomes, satisfaction and preferences, quality of life, and other patient outcomes.

#### Mortality {#CD001271-sec4-0011}

Eight trials evaluated mortality ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0014]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0018]). Meta‐analysis of data from these trials suggests that nurse‐led primary care may lead to slightly fewer deaths among certain groups of patients, compared to doctor‐led care. Among those people who received doctor‐led care, 6 per 1000 people died. Among those people who received nurse‐led care, between 4 and 6 people per 1000 died (RR 0.77, 95% CI 0.57 to 1.03, low certainty evidence). Data show no evidence of statistical heterogeneity (I^2^ = 0%, 95% CI 0 to 68; [Analysis 1.1](#CD001271-fig-00101){ref-type="fig"}). The evidence is of low certainty owing to a wide confidence interval that includes no effect (imprecision) and clinical heterogeneity, as the trials contributing to this estimate are quite varied (some focus on people with specific health issues and others on more generalist primary care attenders). Excluding from the meta‐analysis a trial assessed as cluster‐randomised did not greatly change the result (RR 0.56, 95% CI 0.33 to 0.95) ([@CD001271-bbs2-0009]). Results did not differ considerably in the other sensitivity analyses.

#### Other health status outcomes {#CD001271-sec4-0012}

We grouped health status outcomes into clinical outcomes (e.g. blood pressure, cholesterol, glycated haemoglobin (HbA1c)) and self‐reported measurements of health status, including measures related to physical functioning (e.g. pain, Disease Activity Score (DAS)) and lifestyle factors (e.g. smoking, alcohol consumption, exercise).

##### Clinical outcomes {#CD001271-sec5-0004}

Three trials focussing on patients with cardiovascular disease or diabetes evaluated clinical outcomes ([@CD001271-bbs2-0006]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0018][)]{.ul}. Meta‐analyses for blood pressure levels suggest that, compared to doctor‐led care, nurse‐led primary care probably slightly improves blood pressure outcomes for both systolic blood pressure (MD ‐3.73, 95% CI ‐6.02 to ‐1.44, moderate‐certainty evidence; [Analysis 1.5](#CD001271-fig-00105){ref-type="fig"}) and diastolic blood pressure (MD ‐2.54, 95% CI ‐4.57 to ‐0.52, moderate‐certainty evidence; [Analysis 1.6](#CD001271-fig-00106){ref-type="fig"}). For both outcomes, data show no evidence of statistical heterogeneity (systolic blood pressure: I^2^ = 0%, 95% CI 0 to 90; diastolic blood pressure: I^2^ = 0%). Assessment of moderate‐certainty evidence is due to high risk of bias in one of the included studies ([@CD001271-bbs2-0012][)]{.ul}. Results did not change considerably under [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}.

A meta‐analysis for HbA1c suggest that nurse‐led primary care probably leads to similar outcomes as doctor‐led care and a meta‐analysis for cholesterol suggest that nurse‐led primary care leads to similar outcomes as doctor‐led care for patients with heart failure or diabetes (HbA1c levels: MD 0.08, 95% CI ‐0.25 to 0.41, moderate‐certainty evidence; [Analysis 1.8](#CD001271-fig-00108){ref-type="fig"}; total cholesterol: MD ‐0.15, 95% CI ‐0.32 to 0.02, high‐certainty evidence; [Analysis 1.7](#CD001271-fig-00107){ref-type="fig"}). For both outcomes, data show no evidence of statistical heterogeneity (cholesterol: I^2^ = 0%, 95% CI 0 to 90; HbA1c: I^2^ = 0%). The assessment of moderate‐certainty evidence for HbA1c evidence is due to high risk of bias in one of the included studies ([@CD001271-bbs2-0012][)]{.ul}. Results did not change considerably under [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}.

##### Self‐reported measurements of health status {#CD001271-sec5-0005}

Twelve trials provided self‐reported measurements of health status ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0014]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0018]). Two trials among patients with rheumatological diseases ([@CD001271-bbs2-0008]; [@CD001271-bbs2-0013]) assessed the outcomes disease activity in rheumatoid arthritis and pain. Meta‐analyses for DAS and pain suggest that nurse‐led primary care, compared to doctor‐led care, for patients with rheumatological disease probably leads to similar outcomes for DAS and pain (DAS: MD 0.04, 95% CI ‐0.17 to 0.24, moderate‐certainty evidence; [Analysis 1.9](#CD001271-fig-00109){ref-type="fig"}; pain: MD 0.76, 95% CI ‐3.85 to 5.38, moderate‐certainty evidence; [Analysis 1.3](#CD001271-fig-00103){ref-type="fig"}). For both outcomes, there was no evidence of statistical heterogeneity (DAS: I^2^ = 1%; pain: I^2^ = 0%). The evidence is of moderate certainty owing to indirectness, as only patients with rheumatoid arthritis were included. Results did not change considerably under [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}.

We included in a meta‐analysis three studies assessing physical functioning. Results suggest that, compared to doctor‐led care, nurse‐led primary care may lead to little or no difference in physical functioning (RR 1.03, 95% CI 0.98 to 1.09, low‐certainty evidence; [Analysis 1.2](#CD001271-fig-00102){ref-type="fig"}). Results showed statistical heterogeneity (I^2^ = 62%, 95% CI 0 to 87, P = 0.07). The evidence is of low certainty owing to inconsistency and high risk of bias. Results did not change considerably when a trial assessed as having high risk of bias ([@CD001271-bbs2-0002]) was excluded under [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}.

In addition, studies measured a large number of other outcomes related to health status and lifestyle. It was not possible to pool these results because of the wide range of outcomes assessed, but results suggest that care provided by nurses was at least as good as care provided by doctors. We have summarised the details in [Table 3](#CD001271-tbl-0003){ref-type="table"}.

#### Satisfaction and preferences {#CD001271-sec4-0013}

Ten trials measured satisfaction with care ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]). This outcome was assessed in many different ways across trials; therefore we could include only seven trials in a meta‐analysis ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017]). This showed that patient satisfaction is probably slightly higher in nurse‐led primary care than in doctor‐led primary care (SMD 0.08, 95% CI 0.01 to 0.15, moderate‐certainty evidence; [Analysis 1.10](#CD001271-fig-00110){ref-type="fig"}). The evidence is of moderate certainty owing to inconsistency (I^2^ = 56%, 95% CI 23 to 74), suggesting that the extent to which nurse‐led care increased patient satisfaction varied considerably with the context of care. Results did not change considerably under [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}. Findings of trials not included in this meta‐analysis also suggest that patients are probably at least as satisfied with nurse‐led care as with doctor‐led care. [Table 4](#CD001271-tbl-0004){ref-type="table"} summarises the data for all trials that assessed this outcome.Table 2Patient outcome: satisfaction and preference**StudySatisfaction, preference**[@CD001271-bbs2-0001][Overall satisfaction:]{.ul} nurse triage vs GP triage MD\
2.60 (95% CI 0.58 to 4.63)^a^[@CD001271-bbs2-0004][Overall satisfaction]{.ul}: nurse vs doctor (0 to 10), MD ‐0.015, P = 0.83\
[Communication/attitude (1 to 6)]{.ul}\
‐ Understanding: nurse vs doctor, MD ‐0.015, P = 0.41\
‐ Telling the plan: nurse vs doctor, MD ‐0.02, P = 0.74\
‐ Explaination goals and treatment: nurse vs doctor, MD ‐0.01, P = 0.76\
‐ Importance advice: nurse vs doctor, MD ‐0.07, P = 0.17\
‐ Appropriate attention: nurse vs doctor, MD 0.01, P = 0.78\
[Provision of information (1 to 6)]{.ul}\
‐ Cause of problems: nurse vs doctor, MD ‐0.08, P = 0.21\
‐ Relief of symptoms: nurse vs doctor, MD ‐0.04, P = 0.47\
‐ Duration of illness: nurse vs doctor, MD ‐0.09, P = 0.25\
‐ Change of recurrence: nurse vs doctor, MD ‐0.15, P = 0.08\
‐ What to do: nurse vs doctor, MD ‐0.06, P = 0.45\
*Subgroup at least 1 chronic condition*\
[Satisfaction:]{.ul} NP 8.35 (1.07) vs GP 8.11 (1.32), P = 0.02\
[Judgement seeing the right professional:]{.ul} P = 0.35^b^\
[Attending same provider in future:]{.ul} P = 0.67\
[Recommendation to others:]{.ul} P = 0.41[@CD001271-bbs2-0007][Satisfaction:]{.ul}\
‐ Satisfaction with duration of the visit (0 to 10): doctor 8.1, nurse 8.4; MD (95% CI%) 0.256 (0.016 to 0.496)^a^\
‐ Satisfaction with personal attention (0 to 10): doctor 8.1, nurse 8.4, MD (95% CI%) 0.240 (0.003 to 0.476)^a^\
‐ Satisfaction with explanations and information received in the visit (0 to 10): doctor 8.3, nurse 8.5, MD (95% CI%) 0.240 (0.015 to 0.495)^a^\
[Provider preference:]{.ul}\
More than 40% of patients in each group expressed indifference. In the control group, 13.9% of patients would prefer to be seen by a nurse, as opposed to 20.9% in the intervention group.^a^[@CD001271-bbs2-0008][Confidence:]{.ul}\
‐ NRS confidence: nurse vs doctor: 0.20 (95% CI ‐0.29 to 0.69), P = 0.42[@CD001271-bbs2-0010][Provider preference:]{.ul} doctor 5.72 vs nurse 9.80, P \< 0.001. Possible range 0 to 20; higher scores indicate a more positive view of the provider.[@CD001271-bbs2-0012][Satisfaction (9 items):]{.ul} no difference in overall satisfaction, or on any of the 9 subscales^a^\
[Would recommend provider to others]{.ul}: no difference^a^[@CD001271-bbs2-0013][Leeds Satisfaction Questionnaire ‐ LSQ]{.ul}\
Week 26\
‐ LSQ‐General: nurse vs doctor effect size: 0.17, P = 0.036\
‐ LSQ‐Information: nurse vs doctor effect size: 0.08, P = 0.327\
‐ LSQ‐Empathy: nurse vs doctor effect size: 0.05, P = 0.557\
‐ LSQ‐Technical: nurse vs doctor effect size: 0.08, P = 0.293\
‐ LSQ‐Attitude: nurse vs doctor effect size: 0.14, P = 0.082\
‐ LSQ‐Access: nurse vs doctor effect size: 0.01, P = 0.936\
Week 52\
‐ LSQ‐General: nurse vs doctor effect size: 0.12, P = 0.183\
‐ LSQ‐Information: nurse vs doctor effect size: 0.09, P = 0.301\
‐ LSQ‐Empathy: nurse vs doctor effect size: 0.05, P = 0.578\
‐ LSQ‐Technical: nurse vs doctor effect size: 0.08, P = 0.369\
‐ LSQ‐Attitude: nurse vs doctor effect size: 0.08, P = 0.375\
‐ LSQ‐Access: nurse vs doctor effect size: 0.10, P = 0.248[@CD001271-bbs2-0015][Satisfaction:]{.ul}\
‐ Professional care: nurse 79.2 (13.4) vs GP 76.7 (15.1), possible range 0 to 100, P = 0.002\
‐ Relationship to provider: nurse 64.3 (15.7) vs GP 64.2 (16.9), possible range 0 to 100, P = 0.945\
‐ Adequacy of time: nurse 73.3 (16.9) vs GP 67.7 (19.3), possible range 0 to 100, P \< 0.001\
‐ Explanation helpful: nurse 88.8% vs GP 87.3%, P = 0.359\
‐ Advice helpful: nurse 86.9% vs GP 83.9%, P = 0.060\
[Provider preference:]{.ul} GP group: 47.5% prefer GP, 2.0% nurse, 50.5% no preference. Nurse group: 31.5% prefer GP, 7.5% nurse, 61% no preference; P \< 0.001[@CD001271-bbs2-0016][Satisfaction]{.ul}: nurses 96%, doctors 97%^a^[@CD001271-bbs2-0017][Satisfaction:]{.ul}\
*Adults*\
‐ Communication: NP 4.35 (0.54) vs GP 4.21 (0.60), P = 0.001\
‐ Distress relief: NP 4.43 (0.47) vs GP 4.26 (0.57), P = 0.001\
‐ Professional care: NP 4.44 (0.49) vs GP 4.22 (0.57), P \< 0.001\
*Children*\
‐ General: NP 4.39 (0.46) vs GP 4.17 (0.57), P \< 0.001\
‐ Communication with parent: no difference\
‐ Communication with child: NP 4.16 (0.63) vs GP 3.67 (0.77), P \< 0.001\
‐ Distress relief: NP 4.41 (0.53) vs GP 4.21 (0.64), P = 0.002\
‐ Adherence intent: no difference[^3]

In addition, investigators measured a large number of other outcomes related to patient satisfaction and preferences. It was not possible to pool these results, but findings suggest that patients are at least as satisfied with nurses as with doctors. We have summarised details in [Table 4](#CD001271-tbl-0004){ref-type="table"}.

#### Quality of life {#CD001271-sec4-0014}

Six trials evaluated quality of life ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]). Meta‐analysis of data from these trials suggests that quality of life may be slightly higher for people receiving nurse‐led primary care, compared to doctor‐led primary care (SMD 0.16, 95% CI 0.00 to 0.31, low‐certainty evidence; [Analysis 1.4](#CD001271-fig-00104){ref-type="fig"}). The evidence is of low certainty owing to inconsistency (I^2^ = 85%, 95% CI 69 to 93) and to imprecision, as the confidence interval touches on the null. The heterogeneity was caused by one trial ([@CD001271-bbs2-0003]), which included a specific patient group (i.e. people who had experienced dyspepsia after direct access gastroscopy). After we excluded this trial, we found that there may be little or no difference in quality of life among patients receiving nurse‐led primary care, compared to doctor‐led primary care (SMD 0.02, 95% CI ‐0.01 to 0.05). The results also did not show evidence of heterogeneity or change considerably under other [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}.

#### Other patient outcomes {#CD001271-sec4-0015}

Investigators measured a large number of other patient outcomes, including patient knowledge (understanding the health issue) and patient enablement (coping with his or her health issues). It was not possible to pool these results, but findings suggest that care provided by nurses was probably at least as good as care provided by doctors. We have summarised the details in [Table 5](#CD001271-tbl-0005){ref-type="table"}.Table 3Patient outcome: compliance and other**StudyComplianceOther**[@CD001271-bbs2-0012][Rating information (5 items):]{.ul} no difference^a,b^[@CD001271-bbs2-0017][Enablement:]{.ul} nurse vs GP, MD = 0.65 (CI ‐1.50 to 0.19), P = 0.13[@CD001271-bbs2-0018][Patient adherence to medical treatment after 1 year of follow‐up nurse vs doctor (95% CI)]{.ul}\
Medication blood pressure: 92.2 vs 84.9 (1.06 to 3.73; P = 0.03)\
Forgetting to take medication: group difference 1.32 (0.88 to 1.97; P = 0.18)\
‐ Never: 52.6 vs 61.0\
‐ Sometimes: 46.8 vs 39.0\
[Patient lifestyle after 1 year of follow‐up nurse vs doctor (95% CI)]{.ul}\
‐ Exercise: 28.6 vs 27.3 (0.73 to 1.67; P = 0.79)\
‐ Alcohol 5 days per week at most: 78.6 vs 75.5 (0.79 to 2.01; P = 0.33)\
‐ Alcohol 2 for woman, 3 for man at most: 79.1 vs 80.6 (0.53 to 1.56; P = 0.73)\
‐ Fat intake: 6.5 vs 7.2 (0.02 to 1.28; P = 0.04)[^4]

### Process of care outcomes {#CD001271-sec3-0027}

Ten trials investigated process of care outcomes ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0018]). We have summarised the data in [Table 6](#CD001271-tbl-0006){ref-type="table"}. Owing to the large variety of approaches used in measuring the process of care, we did not judge it appropriate to pool these data in a meta‐analysis. The individual trial results show some differences between nurses and primary care doctors in process of care measures. For example, investigators reported that nurses gave more advice/information to patients and adhered to guidelines more frequently. However, the quality of patient examinations appeared to be similar between nurses and doctors. Overall, we assessed this evidence to be of very low certainty as the results were non‐comparable and we could not calculate an overall effect size.Table 4Process of care outcomes**StudyProvider care**[@CD001271-bbs2-0001][Difficulty with]{.ul} (nurse triage vs GP triage, MD (95% CI):\
Phone access: 6.49 (--1.26 to 14.25)^a^\
Receiving prompt care: 6.63 (3.23 to 10.03)^a^\
Seeing a doctor or nurse: 3.67 (--0.37 to 7.71)^a^\
Getting medical help: 5.09 (2.69 to 7.50)^a^\
Convenience of care 3.68 (1.13 to 6.24)^a^\
[Problem resolution:]{.ul} nurse triage vs GP triage: 0.41 (--1.86 to 2.67)^a^\
[Process indicators:]{.ul}\
‐ Number of contacts per person: nurse vs GP triage: 1·04 (1·01 to 1·08)^a^\
‐ 23% in the GP‐triage group and 12% in the nurse‐triage group had just 1 contact after their initial consultation request^b^[@CD001271-bbs2-0004][Adherence to guidelines:]{.ul} nurse 79.8%, doctor 76.2%^a,c^[@CD001271-bbs2-0006][Process indicators:]{.ul}\
‐ Patients with last retina control \> 24 months ago (n = 64) referred to an ophthalmologist: nurse 24/34 (70.6) vs GP 11/30 (36.7), P = 0.007\
‐ Patients with feet at‐risk (n = 109) for whom measures were taken: nurse 34/60 (56.7) vs GP 13/49 (26.5), P = 0.001\
‐ Patients referred to an internist to start insulin therapy: nurse 10/102 (9.8) vs GP 2/104 (1.9), P = 0.015\
‐ Patients with HbA1c ≥ 7 at baseline (n = 120), for whom glucose‐lowering therapy was intensified: nurse 53/64 (82.8) vs GP 28/56 (50.0), P = 0.001\
‐ Patients with BP \> 140/90 at baseline (n = 170) for whom blood pressure‐lowering therapy was intensified: nurse 42/85 (49.4) vs GP 24/85 (28.2), P = 0.005\
‐ Patients not meeting target values for lipid profile at baseline (n = 55), for whom lipid‐lowering therapy was intensified: nurse 13/29 (44.8) vs GP 13/26 (50.0), P = 0.147[@CD001271-bbs2-0011][Adequate assessment:]{.ul}\
‐ Clinical assessment: nurse vs GP: 9% (95% CI ‐3 to 22), P = 0.13\
‐ Blood pressure: no difference^c^\
‐ Cholesterol: no difference^c^\
‐ Smoking status: no difference^c^[@CD001271-bbs2-0012][Documentation of provider behaviour diabetes care:]{.ul}\
‐ Education (8 items): overall 'any education': nurse 84,9% vs medical doctor 42.4% (P \< 0.001). With regard to specific items, nurse more education: 4 out of 7 topics: nutrition, weight, exercise, and medication (P \< 0.01)\
‐ History taken (5 items): no difference\
‐ Monitoring (9 items): nurse ordered/carried out more laboratory tests, such as urinalysis (nurse 80.2%, medical doctor 55.9%, P \< 0.01) and glycosylated haemoglobin (A1C value) (nurse 81.4, medical doctor 66.1, P \< 0.05); nurse reported more frequently height of patients (nurse 91.9%, medical doctor 71.2%, P \< 0.01). On other 6 items, no difference\
‐ Referral (1 item): no differences[@CD001271-bbs2-0013][Interventions:]{.ul}\
‐ Giving patient education: nurse \> doctor; RR (95% CI) 1.76 (1.15 to 2.69), P = 0.009\
‐ Giving psychosocial support: nurse \> doctor; RR (95% CI) 3.29 (2.55 to 4.24), P \< 0.0001[@CD001271-bbs2-0015][Provision of information:]{.ul}\
‐ Self‐medication: nurse 22.2% vs GP 13.7%, P \< 0.001\
‐ Self‐management: nurse 81.7% vs GP 57.6%, P \< 0.001[@CD001271-bbs2-0016][Adequate treatment:]{.ul}\
‐ Drug treatment: nurses 71%, doctors 75%^a^\
‐ Management of episodes: nurses 69%, doctors 66%^a^[@CD001271-bbs2-0018][Lifestyle and medical intervention nurse vs doctor:]{.ul}\
‐ Smoking behaviour 8.2% vs 3.2%^a^\
‐ Blood pressure 35.4% vs 26.6% (1.01 to 2.24; P = 0.04)\
‐ Lipids 47.1 vs 22.3 (1.98 to 4.43; P \< 0.01)\
‐ Weight 36.9 vs 7.6 (4.26 to 12.52; P \< 0.01)\
‐ Exercise 19.4 vs 3.2^a^\
‐ Food intake 14.6 vs 3.2^a^\
‐ Medication 22.3 vs 14.7 (0.99 to 2.59; P = 0.05)\
‐ None 22.8 vs 43.2 (1.69 to 3.86; P \< 0.01)\
[Asked about the use of medication: nurse vs doctor]{.ul}\
Group difference 2.12 (1.38 to 3.26; P \< 0.01)\
‐ Never 57.4 vs 75.4\
‐ Sometimes 20.0 vs 14.4\
‐ Often 22.1 vs 9.7[@CD001271-bbs2-0017][Examinations:]{.ul} nurse vs GP: MD 0.19 (95% CI ‐0.03 to 0.71), P = 0.072[^5]

### Utilisation outcomes {#CD001271-sec3-0028}

Sixteen trials measured utilisation and costs ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0018]). The range of outcomes varied across trials and can be grouped into four categories: length and frequency of consultations; numbers of prescriptions, tests, and investigations ordered; use of other healthcare services, such as hospital admissions or referral to other professionals ([Table 7](#CD001271-tbl-0007){ref-type="table"}); and costs ([Table 8](#CD001271-tbl-0008){ref-type="table"}). Findings for each of these categories are presented below.Table 5Utilisation outcomes**StudyNumber, length, and frequency of consultationsNumbers of prescriptions, tests, and investigationsUse of other services**[@CD001271-bbs2-0004][Referrals:]{.ul} nurse 12%, doctor 14.2%, P = 0.24^a^[@CD001271-bbs2-0005]**Compared to qualified doctors**\
[Consultation rate:]{.ul}\
Nurses 3.52 vs qualified doctors 4.03 (P \> 0.05)\
**Compared to residents (trainee doctors)**\
[Consultation rate:]{.ul}\
Nurses 3.52 vs residents 2.95 (P \< 0.05)**Mean utilisation rate:**\
**Compared to qualified doctors**\
[Tests & investigations:]{.ul}\
[Lab tests]{.ul}: NP 32.67, doctor 29.46, P \> 0.05\
[Radiological tests (total)]{.ul}: NP 1.68. doctor 1.37, P \> 0.05\
‐ CT/MRI: NP 0.32, doctor 0.13, P \< 0.05\
‐ Ultrasound: NP 0.16, doctor 0.07, P \< 0.05\
**Compared to residents (trainee doctors)**\
[Tests & investigations:]{.ul}\
[Lab tests]{.ul}: NP 32.67, doctor 28.26, P \> 0.05\
‐ Urinalysis: NP 1.31, doctor 0.99, P \< 0.05\
‐ Thyroid function: NP 0.37, doctor 0.19, P \< 0.05\
[Radiological tests]{.ul}: NP 1.68, doctor 1.48, P \> 0.05**Mean utilisation rate:**\
**Compared to qualified doctors**\
[Hospital admission:]{.ul} NP 0.43, doctor 0.33, P \> 0.05\
[Emergency room visits:]{.ul} NP 1.22, doctor 1.23, P \> 0.05\
[Specialty visits]{.ul}:\
NP 5.35, doctor 4.26, P \> 0.05\
**Compared to residents (trainee doctors)**\
[Hospital admission:]{.ul} NP 0.43, doctor 0.31, P \> 0.05\
[Emergency department visits:]{.ul} NP 1.22, doctor 1.05, P \> 0.05\
[Specialty visits]{.ul}: NP 5.35, doctor 4.21, P \> 0.05[@CD001271-bbs2-0006][Mean number of visits:]{.ul} nurse 6.1, GP 2.8 (P \< 0.0001)\
[Total duration of visits:]{.ul} significantly higher in nurse group^a^\
[Consultation of nurses\' patients with GP:]{.ul} Median number of these consultations per patient was 1.4 (25 to 75 quartiles: 0.0 to 2.0) with median time of 1.0 (25 to 75 quartiles: 0.0 to 3.3) minute[@CD001271-bbs2-0007][Level of resolution by nurses:]{.ul}\
Nurses led 86.3% (95% CI 83.6 to 88.7) of consultations without referral to GP (referrals according to protocol indication not included)[@CD001271-bbs2-0008][Proportion nurse‐led vs doctor‐led:]{.ul}\
‐ Cortisone injections in addition to regular rheumatologist monitoring visits (1:0.7; P = 0.463)\
‐ Blood tests (1:3.9; P = 0.014)\
‐ Radiography (1:1.6; P = 0.162)\
‐ Pharmacological therapy (1:1.1; P = 0.029)[Proportion nurse‐led vs doctor‐led:]{.ul}\
‐ Additional telephone calls to a rheumatology nurse (1:1.8; P = 0.060)\
‐ Additional telephone calls to a rheumatologist (1:1.9; P =0.287)\
‐ Additional rheumatologist visits (1:2.4; P = 0.077)\
‐ Team rehabilitation in in‐patient settings (0:79; P = 0.086)\
‐ Team rehabilitation in out‐patient settings (15:0; P = 0.135)\
‐ Occupational therapist treatments (0:3.0; P = 0.162)\
‐ Psychosocial treatments (0:1.0; P = 0.152)\
‐ Specialist consultations (1:1.0; P = 0.949)[@CD001271-bbs2-0009][Impact on GP workload:]{.ul}\
‐ Telephone advice from GP: fewer with nurse‐led care, 35% reduction^b^\
‐ Surgery visits: 10% fewer with nurse‐led care^b^\
‐ Home visits: 6% fewer home visits during intervention period^b^[Hospital admission within 24 hours:]{.ul} nurse 2%, GP 6.5%, RR 0.31 (95% CI 0.07 to 1.42)\
[Hospital admission within 3 days]{.ul}: nurse 5%, GP 6.5%, RR 0.77 (95% CI 0.26 to 2.28)\
[Emergency department visit:]{.ul} nurse 3%, GP 2%, RR 1.84 (95% CI 0.31 to 10.82)[@CD001271-bbs2-0010][Consultation length]{.ul}: doctor 15 minutes, nurse 30 minutes^c^\
[Consultation rate:]{.ul} doctor 150 visits, nurse 345 visits^c^[Days in hospital:]{.ul} doctor 68 days, nurse 45 days^c^[@CD001271-bbs2-0011][Prescriptions:]{.ul}\
‐ Antihypertensives: no difference, P = 0.35^a^\
‐ Lipid lowering: no difference, P = 0.63^a^\
‐ Antiplatelet: nurse 8% (95% CI 1% to 9%) more than GP (P = 0.031)[@CD001271-bbs2-0012][Consultation rate:]{.ul} Doctor patients had higher primary care utilisation than nurse practitioner patients (2.50 vs 1.76 visits, P = 0.05)[Speciality visits:]{.ul} no difference^d^, P = 0.61[@CD001271-bbs2-0013][Consultation length:]{.ul}\
Mean total consultation time: nurse 111 min, doctor 71 min^a,b^\
[Consultation rate:]{.ul}\
Patients attending all 5 sessions: nurse 92%, doctor 85%^a,b^‐ Change in medicines: nurse \< doctor; RR (95% CI) 0.58 (0.43 to 0.79), P = 0.0006\
‐ Dosage changes: nurse \< doctor; RR (95% CI) 0.52 (0.34 to 0.79), P = 0.0020\
‐ Intra‐articular injections: nurse \< doctor; RR (95% CI) 0.82 (0.50 to 1.35), P = 0.4400\
‐ Intramusclar injections: nurse \< doctor; RR (95% CI) 0.73 (0.45 to 1.19), P = 0.2100\
‐ Non‐protocol bloods: nurse \< doctor; RR (95% CI) 1.02 (0.74 to 1.40), P = 0.9100‐ Referral to physiotherapy: nurse \< doctor; RR (95% CI) 1.21 (0.62 to 2.39), P = 0.5800\
‐ Referral to occupational therapy: nurse \< doctor; RR (95% CI) 1.74 (0.76 to 3.96), P = 0.1900\
‐ Referral to podiatry: nurse \< doctor; RR (95% CI) 0.89 (0.37 to 2.14), P = 0.8000\
‐ Conferrals: nurse \< doctor; RR (95% CI) 2.92 (1.77 to 4.83), P \< 0.0001\
‐ Referral to other consultants: nurse \< doctor; RR (95% CI) 0.58 (0.11 to 3.11), P = 0.5200[@CD001271-bbs2-0015][Out‐of‐hours calls:]{.ul} nurse 0.9% vs GP 1.8%, P = 0.218[@CD001271-bbs2-0017][Physical examinations]{.ul}: nurse vs GP; MD 0.19 (95% CI ‐0.03 to 0.71), P = 0.072[@CD001271-bbs2-0018][Referred to professional nurse vs doctor:]{.ul}\
‐ Dietician 17.0 vs 8.9^b^\
‐ Physiotherapist 3.1 vs 1.9^b^\
‐ Cardiovascular specialist 1.9 vs 6.3^b^\
‐ Visited a cardiovascular specialist 46.3 vs 45.3 (0.84 to 1.79; P = 0.30)\
‐ Admission into hospital because of CVD 10.4 vs 13.4 (0.43 to 1.38; P = 0.38)[^6]Table 6Utilisation; cost outcomes**StudyCosts based onCost outcomes**[@CD001271-bbs2-0001]Staff trainingSetup of the interventionsCost of computer decision support software in nurse triageClinician triage timePatient‐level quantities of resource use on other primary care contacts[Total costs:]{.ul}\
Mean 28‐day cost estimates for primary outcome contacts:\
*Nurses* ‐ £75·68 (63·09)\
*GPs* ‐ £75·21 (65·45)[@CD001271-bbs2-0003]Medication use[Costs of medication use:]{.ul}\
*Nurses* -- mean £35.5 (SD £48.8)\
*Doctors* -- mean £71.7 (SD £ 63.1)\
*Mean difference (adjusted baseline level):* £39.6 (95% CI 24.2 to 55.1); P \< 0.001[@CD001271-bbs2-0004]Direct healthcare costsPrescriptionsDiagnostic proceduresReferrals (in the 2 weeks after consultation)Follow‐up consultationLength of consultationsSalary costsCosts outside the healthcare sectorSick leave days[Total direct healthcare costs:]{.ul}\
*Nurses*: €31.94\
*Doctors:* €40.15\
*Mean difference (95% CI):*\
€8.21 (3.56 to 12.85); P = 0.001\
[Total direct healthcare costs and productivity:]{.ul}\
*Nurses*: €140.40\
*Doctors:* €145.87\
*Mean difference (95% CI):*\
€1.48 (‐4.94 to 7.90); P = 0.65\
*Subgroup younger than 65 years:*\
[Total direct healthcare costs and productivity:]{.ul}\
*Nurses*: €161.57\
*Doctors:* €170.75\
*Mean difference (95% CI):*\
€9.18 (4.84 to 13.88); P \< 0.001[@CD001271-bbs2-0008]Fixed monitoring (monitoring visit at 6 months to a rheumatology nurse, a rheumatologist; for both groups, a monitoring visit at 12 months to a rheumatologist and monitoring blood tests)Variable monitoring (additional telephone calls to a rheumatology nurse, additional telephone calls to a rheumatologist (additional rheumatologist visits, cortisone injections in addition to regular rheumatologist monitoring visits, and additional blood tests))Rehabilitation (team rehabilitation days of care in in‐patient and out‐patient settings, individual physiotherapy treatments, occupational therapist treatments, and psychosocial treatments)Specialist consultations (orthopaedic surgeon, hand surgeon, dermatologist, and orthotist)Radiography (standard x‐ray and dual energy x‐ray absorptiometry (DEXA) scanning)Pharmacological therapy[Total annual rheumatology care per patient:]{.ul}\
*Nurse‐led:* €14107,70\
*Doctor‐led:* €16274,90\
*Mean difference (95% CI):*\
−2167.2 (−3757.3 to −641.7)\
P = 0.004[@CD001271-bbs2-0009]Costs for nurse telephone consultationRecruitmentNurse salariesIndemnity insuranceCo‐operative managementEducation programme1 H grade -- 0.25 whole time equivalent10 days lecturer BTechnical supportComputersDecision support softwareFurnitureTelephonesDigital tape recorderSavingsEmergency hospital admissionHome visits by general practitionerSurgery attendance within 3 days[Annual direct cost:]{.ul}*Nurse‐led service:* ‐ £81,237 more than doctor‐led service\
[Savings:]{.ul}\
Generated in reduced hospital and primary care utilisation £94,422\
[Net reduction in costs:]{.ul}*with nurse‐led service*\
£3,728 to £123,824 (determined by sensitivity analysis)[@CD001271-bbs2-0010]Cost per hour of the time of doctors and nursesLength of visitsTotal number of visitsTotal days of in‐patient careUnknown other costs[Total direct cost per year:]{.ul}\
*Nurses* ‐ \$3,251\
*Doctors* ‐ \$4,199\
[Average cost per patient per year:]{.ul}\
*Nurses* ‐ \$98.51\
*Doctors* ‐ \$127.24[@CD001271-bbs2-0013]Resource useHealthcare professional consultations (primary and secondary care)Hospital admissions (day care, in‐patient stays, A&E visits)Investigations and treatments including over‐the‐counter medicationsPrivate out‐of‐pocket expendituresHealthcare service useTravelMedicationAidsSpecial dietary requirementsProductivity losses[NHS resources plus out‐of‐pocket expenditures:]{.ul}\
*Nurses* ‐ mean £1276\
*Doctors* ‐ mean £2286\
(95% CI ‐352 to 1773)\
P = 0.1872[@CD001271-bbs2-0016]^a^DoctorsNurses (including nurse practitioners)Hospital and extended careDentistsOptometrists/OpticiansChiropractorsPodiatristsLaboratoryDiagnostic radiographyDirect cash expenditures[Average cost per patient per year:]{.ul}\
*Nurses* ‐ \$297.01\
*Doctors* -- \$285.67[@CD001271-bbs2-0017]Basic salary costs of each healthcare professionalPrescriptionsTestsReferralsReturn consultations in the following 2 weeks[Total direct cost per consultation:]{.ul}\
*Nurses* -- mean £18.11 (SD £33.43; range £0.66 to £297.1)\
*Doctors* -- mean £20.70 (SD £33.43; range £0.78 to £300.6)\
*Mean difference (adjusted age, sex):* £2.33 (95% CI 1.62 to 6.28); P = 0.247[^7]

#### Consultations {#CD001271-sec4-0016}

Seven trials investigated consultation length ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017]). Four trials provided sufficient data for a meta‐analysis on consultation length ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017]). This analysis suggests that nurses probably have longer consultations than doctors (SMD 0.38, 95% CI 0.22 to 0.54, moderate‐certainty evidence; [Analysis 1.11](#CD001271-fig-00111){ref-type="fig"}). The evidence is of moderate certainty owing to serious inconsistency (I^2^ = 90%, 95% CI 80 to 95). The extent of heterogeneity suggests that differences in consultation length varied considerably with the context of care. On average, consultations with nurses were 39% (95% CI 30% to 52%) longer than those with doctors. Results did not change considerably under [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}. Findings of the trials not included in the meta‐analysis also suggest that consultations in nurse‐led care were probably longer than those in doctor‐led care.

Nine trials investigated consultation rates in primary care (including overall consultation rates, return visits for whatever reason, and home visits) ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017]). Three trials provided sufficient data for a meta‐analysis of scheduled return visits ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017]), and four trials on attended return visits ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017]). Data show that there may be little or no difference in scheduled return visits (RR 1.31, 95% CI 0.89 to 1.94, low‐certainty evidence; [Analysis 1.12](#CD001271-fig-00112){ref-type="fig"}). The number of attended return visits is higher in nurse‐led primary care than in doctor‐led primary care (RR 1.19, 95% CI 1.07 to 1.33, high‐certainty evidence; [Analysis 1.13](#CD001271-fig-00113){ref-type="fig"}). For scheduled return visits, the evidence is of low certainty owing to serious inconsistency (I^2^ = 86%, 95% CI 54 to 92) and imprecision (wide confidence interval). Results did not change considerably under [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}.

Findings of the trials not included in the meta‐analysis were congruent with those reported above . Furthermore, the workload of doctors was probably slightly less where care was led by nurses, compared to where it was led by doctors, as were waiting times for patients in the waiting room. [Table 7](#CD001271-tbl-0007){ref-type="table"} summarises the data for all trials that assessed this outcome.

#### Numbers of prescriptions, tests, and investigations {#CD001271-sec4-0017}

Seven trials evaluated rates of prescriptions, tests, and investigations ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0013]). Four trials provided sufficient data for a meta‐analysis on the number of prescriptions given ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017]), and four trials on the number of tests and investigations ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0013][).]{.ul} Meta‐analyses of data from these trials suggest little or no difference between nurse‐led care and doctor‐led care in the number of prescriptions given (RR 0.99, 95% CI 0.95 to 1.03, high‐certainty evidence; [Analysis 1.14](#CD001271-fig-00114){ref-type="fig"}).

The findings also show that there may be little or no difference in the number of tests/investigations (RR 0.95, 95% CI 0.59 to 1.51, low‐certainty evidence; [Analysis 1.15](#CD001271-fig-00115){ref-type="fig"}). The evidence is of low certainty owing to serious inconsistency (I^2^ = 76%, 95% CI 23 to 86) and a wide confidence interval, suggesting that the number of ordering tests/investigations varied between nurse‐led care and doctor‐led care according to the context of care.

The findings of trials not included in the meta‐analyses also suggest little or no difference between nurse‐led and doctor‐led care in numbers of prescriptions and investigations/tests. [Table 7](#CD001271-tbl-0007){ref-type="table"} summarises the data for all trials that assessed this outcome.

#### Use of other services {#CD001271-sec4-0018}

Thirteen trials investigated people\'s use of services, including referrals, specialty visits, and hospital admissions ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0005]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0008]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0015]; [@CD001271-bbs2-0017]; [@CD001271-bbs2-0018]). Of these trials, four provided sufficient data for a meta‐analysis on hospital referral ([@CD001271-bbs2-0006]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0017]), five for a meta‐analysis on attendance at accident and emergency units ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0015]), and three for a meta‐analysis on hospital admission ([@CD001271-bbs2-0009]; [@CD001271-bbs2-0012]; [@CD001271-bbs2-0013]). These meta‐analyses suggest that there may be little or no difference between nurse‐led care and doctor‐led care in the likelihood of hospital referrals (RR 0.90, 95% CI 0.54 to 1.49, low‐certainty evidence; [Analysis 1.16](#CD001271-fig-00116){ref-type="fig"}[),]{.ul} as well as little or no difference in attendance at accident and emergency units (RR 1.00, 95% CI 0.91 to 1.09, high‐certainty evidence; [Analysis 1.17](#CD001271-fig-00117){ref-type="fig"}[).]{.ul} In addition, there may be little or no difference in hospital admissions (RR 1.04, 95% CI 0.78 to 1.39, low‐certainty evidence; [Analysis 1.18](#CD001271-fig-00118){ref-type="fig"}). For referrals, evidence is of low certainty owing to inconsistency (I^2^ = 50%, 95% CI 0 to 86) and a wide confidence interval, suggesting that the extent to which the frequency of referrals differs between nurse‐led care and doctor‐led care varied with the context of care. For hospital admissions, the evidence is of low certainty owing to risk of bias in one of the included trials ([@CD001271-bbs2-0012]) and a wide confidence interval. Results did not change considerably in the [Sensitivity analysis](#CD001271-sec3-0017){ref-type="sec"}.

Findings of the trials not included in the meta‐analyses also suggest little or no difference between nurse‐led and doctor‐led care on use of other services. [Table 7](#CD001271-tbl-0007){ref-type="table"} summarises the data for all trials that assessed this outcome.

#### Costs {#CD001271-sec4-0019}

Nine trials investigated the cost of care ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0002]; [@CD001271-bbs2-0003]; [@CD001271-bbs2-0004]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0013]; [@CD001271-bbs2-0016]; [@CD001271-bbs2-0017]) ([Table 8](#CD001271-tbl-0008){ref-type="table"}). Three trials estimated cost of care for nurses providing first contact care ([@CD001271-bbs2-0004]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0017]), two trials for nurses providing first contact and ongoing care ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0016]), and three trials for nurses providing ongoing care for patients with chronic disease ([@CD001271-bbs2-0003]; [@CD001271-bbs2-0010]; [@CD001271-bbs2-0013]). Individually, the trials appear to suggest little or no difference in cost of care between nurse‐led care and doctor‐led care. However, owing to the large variety of approaches used to value resources and calculate costs, we judged the results to be non‐comparable and did not pool these in a meta‐analysis. We therefore assessed the certainty of the evidence as very low.

Discussion {#CD001271-sec1-0006}
==========

Summary of main results {#CD001271-sec2-0011}
-----------------------

This review identified 18 randomised trials evaluating the impact of nurses working as doctors' substitutes. One study was from a middle‐income country, and all of the other studies were from high‐income countries. The type of nursing cadres involved in the studies was often unclear or varied between and even within studies.

Findings suggest that care delivered by nurses, compared to care delivered by doctors, probably leads to similar or better health outcomes for a broad range of patient conditions (moderate‐certainty evidence).

Nurse‐led primary care may lead to slightly fewer deaths among certain groups of patients, compared to doctor‐led care. However, the results vary and it is possible that nurse‐led primary care makes little or no difference to the number of deaths.Blood pressure outcomes are probably slightly improved in nurse‐led primary care. Other clinical or health status outcomes are probably similar.Patient satisfaction is probably slightly higher in nurse‐led primary care. Quality of life may be slightly higher.

We are uncertain of the effects of nurse‐led care, compared to doctor‐led care, on processes of care such as patient education and adherence to guidelines. The effect of nurse‐led care on utilisation is mixed and depends on the type of outcome. Consultations are probably longer in nurse‐led primary care, and numbers of attended return visits are slightly higher for nurses than for doctors. We found little or no difference between nurses and doctors in the number of prescriptions and attendance at accident and emergency units. There may also be little or no difference in the number of tests and investigations, hospital referrals and hospital admissions between nurses and doctors. We are uncertain of the effects of nurse‐led care on the cost of care because the certainty of this evidence was assessed as very low.

An overview can be found in [Table 1](#CD001271-tbl-0001){ref-type="table"}.

Overall completeness and applicability of evidence {#CD001271-sec2-0012}
--------------------------------------------------

Several issues need to be considered when one is making judgements about the applicability of these findings in primary care systems. First, we were able to identify a large number of studies published up to March 2017, which were sufficient to address all objectives of the review. These studies are highly varied in terms of types of nurses (with regard to both educational level and nurses\' roles), healthcare systems, and geographical settings, and they examine care provided to general patient populations as well as to specific groups of patients, such as people with cardiovascular disease, diabetes and rheumatological diseases. Next, we found a large variation in outcome measures. For a number of outcomes there were only a few contributing studies whereas for some other outcomes a relative large number of studies contributed to the evidence. Furthermore, often details (such as nursing education level) were missing from study reports. Therefore we were not able to conduct planned subgroup analyses. As a result, it is not possible to draw conclusions on the influence of nurse type on outcomes. In addition, all but one of the included studies were conducted in high‐income country settings. Second, in some studies, interventions in nurse‐led and doctor‐led groups were somewhat different. For example, nurses had protocols or were offered a computerised decision tool, and doctors were not ([@CD001271-bbs2-0001]; [@CD001271-bbs2-0006]; [@CD001271-bbs2-0007]; [@CD001271-bbs2-0009]). In other studies, nurses' patients were given an appointment but doctors' patients were only advised to see their doctor ([@CD001271-bbs2-0003]), or nurse‐led care included a longer time slot for consultations ([@CD001271-bbs2-0013]). These differences in the interventions provided might have influenced study outcomes. Last, over the ten years since our previous review was published, primary care services have changed considerably in many settings. However, we did not identify a trend in types of nurse substitutions for doctors or in changes in outcomes assessed that might reflect changes in primary care services. The reasons for this are not clear.

Quality of the evidence {#CD001271-sec2-0013}
-----------------------

This review included studies from a wide range of nursing levels, patient groups, and countries. We were able to identify evidence on many different outcomes, but certainty of this evidence varies. All studies had some methodological shortcomings, such as contamination and lack of blinding both patients and personnel, which sometimes led to downgrading of the evidence owing to risk of bias. Although lack of blinding is considered a shortcoming, blinding is often not possible for organizational interventions, such as the substitution of one kind of health care provider with another. While the impact of this on outcomes is unclear, we believe the impact on patient satisfaction and experiences with care is likely to be limited. For example, a Dutch study which evaluated the impact of nurse practitioners in acute primary care settings showed that patients often do not know the profession of their care provider, even when the care provider had introduced themselves at the start of the consultation (only 18% of the patients treated by nurse practitioners remembered this) ([@CD001271-bbs2-0076]). The study suggests that patients do not judge the practitioner on the basis of their profession but rather on their competencies. Not blinding personnel may affect collaboration, as acceptance of a new professional is one of the main factors influencing skill mix changes ([@CD001271-bbs2-0054]). This influence could go either way: when a new professional is first introduced, other professionals and patients may be uncertain about the competencies of the new professional. However, over time the new professional may be accepted by both patients and other professionals. This has been shown in a recent study in which patients were more satisfied with the care provided by nurses over time ([@CD001271-bbs2-0076]). It is unclear whether this effect might also impact on patient outcomes, process of care outcomes and resource utilization.

For many meta‐analyses, measures of statistical heterogeneity were high indicating inconsistency across the included trials. Even where statistical heterogeneity was not detected, clinical heterogeneity may be present due to the range of types of nurses, health issues and settings included in the review ([@CD001271-bbs2-0051]). Wide confidence intervals (imprecision) were another common reason to downgrade.

For some studies and outcomes, we were not able to conduct meta‐analyses owing to the diversity of the outcomes assessed. For these studies, we could only describe the results narratively, which made drawing overall conclusions difficult.

Potential biases in the review process {#CD001271-sec2-0014}
--------------------------------------

Our search strategy was designed to maximise sensitivity (detecting relevant research) at the expense of specificity (excluding irrelevant research). Even so, relevant research proved difficult to identify, and some studies may have been missed.

We conducted this review according to Cochrane standards. Therefore, we are confident in the quality of the review itself. Although publication bias cannot be ruled out in this area ([@CD001271-bbs2-0034]), it seems unlikely that this bias could be substantial, as the clinical and research communities are equally interested in whether nurses perform as well as or better than doctors, or the reverse.

Agreements and disagreements with other studies or reviews {#CD001271-sec2-0015}
----------------------------------------------------------

Results of this update are similar to those of the original review ([@CD001271-bbs2-0079]) in terms of health outcomes for patients, process of care, and resource utilisation.

Several other published reviews have examined nurses in primary care ([@CD001271-bbs2-0030]; [@CD001271-bbs2-0045]; [@CD001271-bbs2-0046]; [@CD001271-bbs2-0056]; [@CD001271-bbs2-0057]; [@CD001271-bbs2-0058]; [@CD001271-bbs2-0059]; [@CD001271-bbs2-0060]; [@CD001271-bbs2-0061]; [@CD001271-bbs2-0062]; [@CD001271-bbs2-0063]; [@CD001271-bbs2-0074]). Although the findings of our current review are generally consistent with those of other reviews, differences in findings might be explained by differences in review methods. Our review is most closely related to the reviews of Martínez‐González et al. ([@CD001271-bbs2-0057]; [@CD001271-bbs2-0058]; [@CD001271-bbs2-0059]; [@CD001271-bbs2-0060]; [@CD001271-bbs2-0061]). Although those review authors used inclusion criteria similar to ours, we noted differences in the included studies. There are several possible explanations for these differences. Firstly, there may be differences in the way the type of nurse role revision was labelled, and specifically whether this change was assessed as substitution or supplementation. Other systematic reviews included some studies that we assessed as involving nurses supplementing care provided by doctors rather than taking over tasks of doctors through substitution ([@CD001271-bbs2-0029]; [@CD001271-bbs2-0032]; [@CD001271-bbs2-0033]; [@CD001271-bbs2-0037]; [@CD001271-bbs2-0042]; [@CD001271-bbs2-0044]; [@CD001271-bbs2-0047]; [@CD001271-bbs2-0048]; [@CD001271-bbs2-0049]; [@CD001271-bbs2-0053]; [@CD001271-bbs2-0077]). In these supplementation studies, the intervention nurses provided an intervention that was complementary to usual care or both nurses and physicians were both involved in patient care, providing care as a team rather than providing care separately . Secondly, we included several studies that were not included in the reviews of the Martínez‐González team ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0014]; [@CD001271-bbs2-0016]). Only one of these five studies ([@CD001271-bbs2-0016]) was listed in the table presenting the reasons for exclusions. Martinez‐Gonzalez team argued this study was not real substitution due to the contamination that occurred during the trial, with 30% of patients also treated by physicians at the end of the study. We judged contamination as high risk in this study, but not as a reason to exclude the study. The other four studies ([@CD001271-bbs2-0002]; [@CD001271-bbs2-0009]; [@CD001271-bbs2-0011]; [@CD001271-bbs2-0014]) were not included in the full text screening of papers by Martinez‐Gonsalez. It is therefore unclear whether these papers were not identified due to differences in search strategies or whether these papers were excluded at the title and abstract screening stage of the Martinez‐Gonsalez reviews. We have presented in [Table 9](#CD001271-tbl-0009){ref-type="table"} the key methodological differences between our review and the other reviews mentioned here.Table 7Methodological differences with published reviews on care delivered by nurses compared to doctors in primary care**Focus of other reviewsDifferences from our review**Does not include meta‐analysesIncludes nurses working as supplements according to our definitionIncludes non‐randomised studiesFocusses on particular countriesHas a particular focus on cost outcomes[@CD001271-bbs2-0030]\
This literature review assesses the impact of advanced primary care nursing roles, particularly first contact nursing roles, for patients, nurses themselves, and their colleagues.xxx[@CD001271-bbs2-0045]\
This study used the literature search [@CD001271-bbs2-0046] and aims to estimate resource use for a typical same‐day primary care consultation and the cost difference of employing an extra salaried GP or nurse practitioner.xUKx[@CD001271-bbs2-0046]\
This systematic review compares effects of nurse practitioners and doctors providing care at first point on patient satisfaction, health status, process measures, and quality of care.xxDeveloped countries[@CD001271-bbs2-0057]; [@CD001271-bbs2-0058]; [@CD001271-bbs2-0059]; [@CD001271-bbs2-0060]; [@CD001271-bbs2-0061]\
Several systematic reviews investigating effects of nurses working as substitutes for doctors in primary care on clinical effectiveness, course of disease, process care, resource utilisation, and costs.x[@CD001271-bbs2-0056]\
This systematic review determines the cost‐effectiveness of nurse practitioners delivering primary and specialised ambulatory care.xx[@CD001271-bbs2-0062]\
This structured literature review investigates the value of advance practice nurses in delivering primary care, with a particular emphasis on the contributions of nurse practitioners.xxx[@CD001271-bbs2-0063]\
This systematic reviews compares patient outcomes of care by advanced practice registered nurses (APRNs) to care by other providers (doctors or teams without APRNs).xxxUSA[@CD001271-bbs2-0074]\
This systematic review includes 10 studies evaluating the cost and quality of care provided by APRNs in primary care.x[^8]

Several reviews found similar results to ours in terms of reductions in mortality in nurse‐led primary care compared to doctor‐led primary care, in particular in ongoing care and non‐urgent care provided by nurse practitioners ([@CD001271-bbs2-0057]; [@CD001271-bbs2-0074]). However, one review ([@CD001271-bbs2-0063]) showed that mortality rates were similar across these cadres, possibly owing to differences in review inclusion criteria. All other reviews described results similar to ours in terms of equal or higher health status for patients who received care from nurses compared to doctors ([@CD001271-bbs2-0059]; [@CD001271-bbs2-0063]; [@CD001271-bbs2-0074]).

Other reviews also found that nurse‐led care probably leads to higher patient satisfaction ([@CD001271-bbs2-0046]; [@CD001271-bbs2-0056]; [@CD001271-bbs2-0057]; [@CD001271-bbs2-0074] ); slightly higher quality of life ([@CD001271-bbs2-0057]); longer consultation length; and higher rate of return visits ([@CD001271-bbs2-0045]; [@CD001271-bbs2-0046]; [@CD001271-bbs2-0056]; [@CD001271-bbs2-0060]), compared to doctor‐led care. Our finding that there is little or no difference between nurses and doctors in frequency of prescriptions, tests, and investigations, and in patients' use of other services is similar to that of the [@CD001271-bbs2-0060] review. However, [@CD001271-bbs2-0046] found that nurses‐led care was associated with more investigations but an equal number of prescriptions. It is likely, though, that the findings of the [@CD001271-bbs2-0046] review are now out of date.

While we were uncertain of the effects of nurse‐led care on the cost of care most other reviews ([@CD001271-bbs2-0045]; [@CD001271-bbs2-0056]; [@CD001271-bbs2-0060]; [@CD001271-bbs2-0074])reported that there may be little or no difference in costs of care between nurse‐led care and doctor‐led care. [@CD001271-bbs2-0062] and [@CD001271-bbs2-0063] indicated that nurse care was associated with lower costs. This difference might be explained by a focus on the USA only ([@CD001271-bbs2-0063]), by the inclusion of non‐randomised trials, and by a focus on advanced nurses and nurse practitioners ([@CD001271-bbs2-0062]; [@CD001271-bbs2-0063]). Authors of all reviews agree that evidence of effects of nurse‐led care on costs of care is of low quality.

Authors\' conclusions {#CD001271-sec1-0007}
=====================

Overall, nurse‐doctor substitution in primary care for provision of first contact care (including urgent care), ongoing care for all presenting physical complaints, and follow‐up of patients with a particular chronic condition has been relatively well evaluated. Nurse‐doctor substitution for preventive services and health education in primary care has been less well studied.This review shows that trained nurses, such as nurse practitioners, practice nurses, and registered nurses, probably provide care that is equal to or of better quality than that provided by primary care doctors, and probably achieves equal or better health outcomes for patients. Nurses probably provide more health advice to patients, and probably achieve slightly higher levels of patient satisfaction, compared to primary care doctors ([Table 1](#CD001271-tbl-0001){ref-type="table"}).From this review, we cannot conclude whether it is better to deploy nurses providing care for a broad range of health issues or nurses who target groups of patients. Both approaches seem possible, with at least equal quality of care. Futhermore, the authors of this review cannot draw conclusions on the level of nursing education that leads to the best outcomes when nurses are substituted for doctors. In our review, the educational level of nurses was often unknown. In addition, studies often included a range of nurse roles and types, so we were not able to explore within our review whether evidence shows differences by type of nurse or by nursing role ([@CD001271-bbs2-0055]).Whether nurse‐doctor substitution leads to substantial savings or whether nurse‐doctor substitution is cost‐effective remains unclear. Savings on nurse salaries may be offset by nurses\' longer consultations and nurse rates as compared to doctor rates ([Table 1](#CD001271-tbl-0001){ref-type="table"}). On the other hand, nurses probably adhere better to guideline recommendations, and their patients are probably more likely to attend return visits, which may positively affect health outcomes and reduce costs over the medium to long term.Our review focussed on differences in outcomes between care provided by nurses and care provided by doctors. Although the included studies show effects of an independent practice role for nurses, it is likely that the quality of patient care overall is determined by overall functioning of the primary care team, including nurses, doctors, and other healthcare providers. Only three studies in our review assessed the impact of nurses on doctor behaviour. Policy makers should be aware that implementing nurse substitution in primary care teams may have an influence on the functioning and quality of care delivered by the entire care team.Although this review includes a large number of studies, several important research questions remain.The methodological quality of recent included studies is still variable. Future studies should seek to maximise the numbers of included healthcare providers, rather than the numbers of patients, to reduce the effect of any individual provider on outcomes. Moreover, studies with longer follow‐up periods are needed to provide better insights into impact on health status. For a full understanding of the impact of nurses in primary healthcare teams, we need deeper insights into the functioning of the entire team. Qualitative studies may be useful and could explore questions such as how nurses and doctors work as a team, how they interact, how their roles and responsibilities are defined, and how these agreements on roles and responsibilities affect nurse and doctor behaviours ([@CD001271-bbs2-0068]). Further research is needed to enhance understanding of the limits of substitution, and to explore optimal models of collaboration and deployment of doctors and nurses as part of primary healthcare teams.All studies except one were conducted in high‐income countries, and it is not clear whether results from this single study can be generalised to populations and health systems in middle‐ or low‐income countries. More research in middle‐ and low‐income countries is needed. Moreover, the influence of nursing education level on effects of nurse‐doctor substitution is poorly understood. Reasons include lack of international educational standardisation and insufficient reporting of nursing levels in research papers.Since mortality is very important outcome, and the results of this review show important impacts, with mortality probably being decreased in nurse‐led primary care, this outcome should be assessed in future studies.Costs, particularly societal costs, have not been well investigated, despite the widely held view that nurse‐led care will generate savings. Most studies have major limitations in cost evaluation. Future studies of nurse‐doctor substitution should give more attention to its financial aspects, for example, by performing cost‐effectiveness analyses. Related to this is the question of what impact changes in nurses\' work have on the behaviours of doctors and on their workload. Only three of the included studies evaluated this, despite the widely held view that nurses can 'save' doctors' time.Authors of future reviews about nurse‐doctor substitution must take into account that healthcare services change extensively over time, and that new treatments and innovations may affect healthcare delivery. Organisational changes such as nurse‐doctor substitution are complex and should be treated in a way that leads to a well‐informed understanding of mechanisms and how these may impact outcomes ([@CD001271-bbs2-0072]).
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\#1MeSH descriptor: \[Nurses\] explode all trees987\#2MeSH descriptor: \[Midwifery\] this term only254\#3(nurse or nurses or midwife or midwives):ti,ab9484\#4\#1 or \#2 or \#39809\#5MeSH descriptor: \[Physicians\] this term only613\#6MeSH descriptor: \[General Practitioners\] explode all trees86\#7MeSH descriptor: \[Physicians, Family\] this term only465\#8MeSH descriptor: \[Physicians, Primary Care\] this term only62\#9(physician\* or doctor or doctors or general next practitioner\* or GP or GPs or family next practitioner\* or \"conventional care\" or \"usual care\" or treatment near/1 usual):ti,ab27535\#10\#5 or \#6 or \#7 or \#8 or \#927728\#11MeSH descriptor: \[Primary Health Care\] this term only3089\#12MeSH descriptor: \[Family Practice\] explode all trees2130\#13MeSH descriptor: \[Ambulatory Care\] this term only3034\#14MeSH descriptor: \[Ambulatory Care Facilities\] explode all trees1642\#15MeSH descriptor: \[Community Health Services\] this term only854\#16MeSH descriptor: \[Community Medicine\] this term only39\#17MeSH descriptor: \[Home Care Services\] this term only1563\#18(\"primary care\" or \"primary healthcare\" or \"primary health care\" or primary next practice\* or general next practice\* or family next practice\* or outpatient\* or \"ambulatory care\" or \"community care\" or community next health\* or \"community medicine\" or \"home care\"):ti,ab30438\#19\#11 or \#12 or \#13 or \#14 or \#15 or \#16 or \#17 or \#1835098\#20MeSH descriptor: \[Community Health Nursing\] 2 tree(s) exploded375\#21MeSH descriptor: \[Delegation, Professional\] this term only1\#22\[mh Nurses/UT\]36\#23MeSH descriptor: \[Midwifery\] explode all trees and with qualifier(s): \[Manpower ‐ MA\]2\#24MeSH descriptor: \[Nurse\'s Role\] this term only310\#25(substitut\* or delegat\* or task\* near/2 shift\* or change\* near/2 role\* or expand\* near/2 role\* or extend\* near/2 role\* or expand\* near/2 responsabilit\* or extend\* near/2 responsabilit\* or expand\* near/2 task\* or extend\* near/2 task\*):ti,ab and (nurse or nurses or midwife or midwives):ti,ab123\#26(\"nurse led\" or \"nurse managed\" or \"nurse run\"):ti,ab695\#27\#21 or \#22 or \#23 or \#24 or \#25 or \#261097\#28MeSH descriptor: \[Professional Role\] this term only141\#29MeSH descriptor: \[Professional Autonomy\] this term only32\#30MeSH descriptor: \[Professional Competence\] this term only210\#31MeSH descriptor: \[Clinical Competence\] this term only1984\#32MeSH descriptor: \[Task Performance and Analysis\] this term only1810\#33MeSH descriptor: \[Outcome Assessment (Health Care)\] this term only5316\#34MeSH descriptor: \[Delivery of Health Care\] this term only729\#35(role or competence or performance or skill or skills) near/3 (nurse or nurses or midwife or midwives):ti,ab230\#36\#28 or \#29 or \#30 or \#31 or \#32 or \#33 or \#34 or \#3510124\#37\#4 and \#10 and \#191315\#38\#10 and \#2064\#39\#19 and \#27424\#40\#4 and \#19 and \#36300\#41\#37 or \#38 or \#39 or \#40 in Trials1520

**MEDLINE, Ovid (searched 2017)**

**\#SearchesResults**1exp Nurse Practitioners/og, st, ut \[Organization & Administration, Standards, Utilization\]44592(nurse adj (led or managed or management or run or delivered)).ti.17323or/1‐261274exp Nurses/802205Midwifery/175126(nurse or nurses or midwife or midwives).ti,ab.2388207or/4‐62870848Physicians/787939General Practitioners/534210Physicians, Family/1580211Physicians, Primary Care/219912(physician\* or doctor or doctors or general practitioner\* or GP\* or family practitioner? or conventional care or usual care or treatment as usual).ti,ab.60126813or/8‐1263905714Primary Health Care/6470015Family Practice/6395516Ambulatory Care/3960817exp Ambulatory Care Facilities/5099418Community Health Services/2974519Community Medicine/196620Home Care Services/3108221(primary care or primary healthcare or primary health care or primary practice? or general practice? or family practice? or outpatient? or ambulatory care or community care or community health\* or community medicine or home care).ti,ab.31700622or/14‐2146408523Community Health Nursing/1922624Delegation, Professional/53325exp Nurses/ma, ut \[Manpower, Utilization\]194426Midwifery/ma, ut \[Manpower, Utilization\]35427Nurse\'s Role/3790628(substitut\* or delegat\* or (task? adj2 shift\*) or (change\* adj2 role?) or (expand\* adj2 role?) or (extend\* adj2 role?) or (expand\* adj2 responsabilit\*) or (extend\* adj2 responsabilit\*) or (expand\* adj2 task?) or (extend\* adj2 task?)).ti,ab. and (nurse or nurses or midwife or midwives).mp.351129(nurse led or nurse managed or nurse run).ti,ab.335630or/24‐294616331Professional Role/1072232Professional Autonomy/916233Professional Competence/2280434Clinical Competence/7862035\"Task Performance and Analysis\"/2827936\"Outcome Assessment (Health Care)\"/6032337Delivery of Health Care/7618438Health Resources/ma \[Manpower\]139((role or competence or performance or skill?) adj3 (nurse or nurses or midwife or midwives)).ti,ab.1385740or/31‐3928699341randomized controlled trial.pt.45623542pragmatic clinical trial.pt.53043controlled clinical trial.pt.9331144multicenter study.pt.22258545(randomis\* or randomiz\* or randomly allocat\* or random allocat\*).ti,ab.53008346(trial or multicenter or multi center or multicentre or multi centre).ti.20802547or/41‐46 \[Modified version of CHSSS Max Sensitivity/Precision 2008\]98456048exp Animals/2100824649Humans/166486745048 not (48 and 49)435957251review.pt.225655352meta analysis.pt.7654053news.pt.18131954comment.pt.68558955editorial.pt.43266356cochrane database of systematic reviews.jn.1306157comment on.cm.68558858(systematic review or literature review).ti.9243359or/50‐5876141736047 not 59830997613 and 60487627 and 13 and 22 and 6017986313 and 23 and 60916422 and 30 and 60587657 and 22 and 40 and 6049666or/61‐65253267remove duplicates from 66236068limit 67 to yr=\"2015 ‐ 2017\"350

**MEDLINE, Ovid (searched 2015)**

**\#SearchesResults**1exp Nurses/711382Midwifery/150653(nurse or nurses or midwife or midwives).ti,ab.1995974or/1‐32441755Physicians/619406General Practitioners/22357Physicians, Family/146968Physicians, Primary Care/13559(physician\* or doctor or doctors or general practitioner\* or GP\* or family practitioner? or conventional care or usual care or treatment as usual).ti,ab.50820810or/5‐954025711Primary Health Care/5507512Family Practice/5999913Ambulatory Care/3617414exp Ambulatory Care Facilities/4411415Community Health Services/2702716Community Medicine/189017Home Care Services/2789818(primary care or primary healthcare or primary health care or primary practice? or general practice? or family practice? or outpatient? or ambulatory care or community care or community health\* or community medicine or home care).ti,ab.26338019or/11‐1839757520Community Health Nursing/1846821Delegation, Professional/43122exp Nurses/ma, ut \[Manpower, Utilization\]186323Midwifery/ma, ut \[Manpower, Utilization\]30524Nurse\'s Role/3351025(substitut\* or delegat\* or (task? adj2 shift\*) or (change\* adj2 role?) or (expand\* adj2 role?) or (extend\* adj2 role?) or (expand\* adj2 responsabilit\*) or (extend\* adj2 responsabilit\*) or (expand\* adj2 task?) or (extend\* adj2 task?)).ti,ab. and (nurse or nurses or midwife or midwives).mp.293126(nurse led or nurse managed or nurse run).ti,ab.250927or/21‐264031428Professional Role/870429Professional Autonomy/853730Professional Competence/2050031Clinical Competence/6672332\"Task Performance and Analysis\"/2435333\"Outcome Assessment (Health Care)\"/5001634Delivery of Health Care/6615935Health Resources/ma \[Manpower\]136((role or competence or performance or skill?) adj3 (nurse or nurses or midwife or midwives)).ti,ab.1177437or/28‐3624560438randomized controlled trial.pt.38206039pragmatic clinical trial.pt.9240controlled clinical trial.pt.8847541multicenter study.pt.17724342(randomis\* or randomiz\* or randomly allocat\* or random allocat\*).ti,ab.41033143(trial or multicenter or multi center or multicentre or multi centre).ti.15450344or/38‐43 \[Modified version of CHSSS Max Sensitivity/Precision 2008\]80096745exp Animals/1760652146Humans/136303234745 not (45 and 46)397619848review.pt.192584849meta analysis.pt.5213250news.pt.16570551comment.pt.60650752editorial.pt.36683453cochrane database of systematic reviews.jn.1083954comment on.cm.60650755(systematic review or literature review).ti.5587956or/47‐5567550685744 not 56679799584 and 10 and 19 and 5714405910 and 20 and 57876019 and 27 and 57428614 and 19 and 37 and 5740062or/58‐611809

**CINAHL, EbscoHost (searched 2017)**

**\#QueryResults**S61S59 AND S6062S60PY 2015 OR PY 2016 OR PY 2017453,305S59S49 AND S57 \[Exclude MEDLINE records\]328S58S49 AND S571,354S57S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56218,043S56TI trial or multicenter or \"multi center\" or multicentre or \"multi centre\"46,982S55TI ( randomis\* or randomiz\* or randomly) OR AB ( randomis\* or randomiz\* or randomly)120,964S54(MH \"Multicenter Studies\")22,224S53(MH \"Clinical Trials\")87,754S52(MH \"Randomized Controlled Trials\")30,526S51PT clinical trial52,908S50PT randomized controlled trial30,877S49S44 OR S45 OR S46 OR S47 OR S4830,520S48S4 AND S17 AND S392,019S47S17 AND S275,416S46S8 AND S18801S45S4 AND S8 AND S174,523S44S41 OR S42 OR S4322,587S43TI ( nurse W0 (led or managed or management or run or delivered) )2,045S42(MH \"Clinical Nurse Specialists\")5,529S41(MH \"Nurse Practitioners+\")15,944S40S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39158,594S39TI ( (role or competence or performance or skill or skills) N3 (nurse or nurses or midwife or midwives) ) OR AB ( (role or competence or performance or skill or skills) N3 (nurse or nurses or midwife or midwives) )19,444S38(MH \"Health Resource Utilization/MA\")1,017S37(MH \"Health Care Delivery\")26,197S36(MH \"Outcome Assessment\")19,978S35(MH \"Task Performance and Analysis\")6,102S34(MH \"Professional Competence\")9,330S33(MH \"Nursing Skills\")3,090S32(MH \"Clinical Competence\")21,138S31(MH \"Professional Autonomy\")3,383S30(MH \"Physician\'s Role\")6,094S29(MH \"Nursing Role\")40,396S28(MH \"Professional Role\")21,193S27S19 or S20 or S21 or S22 or S25 or S2649,630S26TI ( \"nurse led\" or \"nurse managed\" or \"nurse run\" ) OR AB ( \"nurse led\" or \"nurse managed\" or \"nurse run\" )3,147S25S23 AND S244,157S24TX ( nurse or nurses or midwife or midwives ) OR TX ( nurse or nurses or midwife or midwives )543,661S23TI ( substitut\* or delegat\* or (task\* N2 shift\*) or (change\* N2 role\*) or (expand\* N2 role\*) or (extend\* N2 role\*) or (expand\* N2 responsabilit\*) or (extend\* N2 responsabilit\*) or (expand\* N2 task\*) or (extend\* N2 task\*) ) OR AB ( substitut\* or delegat\* or (task\* N2 shift\*) or (change\* N2 role\*) or (expand\* N2 role\*) or (extend\* N2 role\*) or (expand\* N2 responsabilit\*) or (extend\* N2 responsabilit\*) or (expand\* N2 task\*) or (extend\* N2 task\*) )13,864S22(MH \"Nursing Role\")40,396S21(MH \"Midwives+/MA/UT\")210S20(MH \"Nurses+/MA/UT\")2,301S19(MH \"Delegation of Authority\")1,623S18(MH \"Community Health Nursing+\")23,411S17S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16141,570S16TI ( \"primary care\" or \"primary healthcare\" or \"primary health care\" or primary W0 practice\* or general W0 practice\* or family W0 practice\* or outpatient\* or \"ambulatory care\" or \"community care\" or community W0 health\* or \"community medicine\" or \"home care\" ) OR AB ( \"primary care\" or \"primary healthcare\" or \"primary health care\" or primary W0 practice\* or general W0 practice\* or family W0 practice\* or outpatient\* or \"ambulatory care\" or \"community care\" or community W0 health\* or \"community medicine\" or \"home care\" )89,176S15(MH \"Home Health Care\")15,668S14(MH \"Community Medicine\")46S13(MH \"Community Health Services\")12,590S12(MH \"Ambulatory Care Facilities+\")9,408S11(MH \"Ambulatory Care\")6,683S10(MH \"Family Practice\")12,121S9(MH \"Primary Health Care\")34,178S8S5 OR S6 OR S7130,746S7TI ( physician\* or doctor or doctors or (general W0 practitioner\*) or GP or GPs or (family W0 practitioner\*) or \"conventional care\" or \"usual care\" or \"treatment as usual\" ) OR AB ( physician\* or doctor or doctors or (general W0 practitioner\*) or GP or GPs or (family W0 practitioner\*) or \"conventional care\" or \"usual care\" or \"treatment as usual\" )105,241S6(MH \"Physicians, Family\")9,248S5(MH \"Physicians\")35,499S4S1 OR S2 OR S3327,119S3TI ( nurse or nurses or midwife or midwives ) OR AB ( nurse or nurses or midwife or midwives )233,516S2(MH \"Midwives+\")9,480S1(MH \"Nurses+\")165,004

**CINAHL, EbscoHost (searched 2015)**

**\#QueryResults**S54S49 OR S50 OR S51 OR S52\
Exclude MEDLINE records259S53S49 OR S50 OR S51 OR S521,199S52S4 AND S17 AND S40 AND S481,065S51S17 AND S27 AND S48245S50S8 AND S18 AND S4848S49S4 AND S8 AND S17 AND S48537S48S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47177,524S47TI trial or multicenter or \"multi center\" or multicentre or \"multi centre\"35,740S46TI ( randomis\* or randomiz\* or randomly) OR AB ( randomis\* or randomiz\* or randomly)99,382S45(MH \"Multicenter Studies\")8,673S44(MH \"Clinical Trials\")80,747S43(MH \"Randomized Controlled Trials\")20,909S42PT clinical trial51,624S41PT randomized controlled trial24,980S40S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39956,442S39TI ( (role or competence or performance or skill or skills) N3 (nurse or nurses or midwife or midwives) ) OR AB ( (role or competence or performance or skill or skills) N3 (nurse or nurses or midwife or midwives) )16,049S38(MH \"Health Resource Utilization/MA\")890,003S37(MH \"Health Care Delivery\")23,166S36(MH \"Outcome Assessment\")17,332S35(MH \"Task Performance and Analysis\")5,148S34(MH \"Professional Competence\")8,480S33(MH \"Nursing Skills\")2,663S32(MH \"Clinical Competence\")18,541S31(MH \"Professional Autonomy\")3,105S30(MH \"Physician\'s Role\")5,524S29(MH \"Nursing Role\")37,124S28(MH \"Professional Role\")18,725S27S19 or S20 or S21 or S22 or S25 or S2645,412S26TI ( \"nurse led\" or \"nurse managed\" or \"nurse run\" ) OR AB ( \"nurse led\" or \"nurse managed\" or \"nurse run\" )2,769S25S23 AND S243,814S24TX ( nurse or nurses or midwife or midwives ) OR TX ( nurse or nurses or midwife or midwives )450,292S23TI ( substitut\* or delegat\* or (task\* N2 shift\*) or (change\* N2 role\*) or (expand\* N2 role\*) or (extend\* N2 role\*) or (expand\* N2 responsabilit\*) or (extend\* N2 responsabilit\*) or (expand\* N2 task\*) or (extend\* N2 task\*) ) OR AB ( substitut\* or delegat\* or (task\* N2 shift\*) or (change\* N2 role\*) or (expand\* N2 role\*) or (extend\* N2 role\*) or (expand\* N2 responsabilit\*) or (extend\* N2 responsabilit\*) or (expand\* N2 task\*) or (extend\* N2 task\*) )12,387S22(MH \"Nursing Role\")37,124S21(MH \"Midwives+/MA/UT\")179S20(MH \"Nurses+/MA/UT\")2,019S19(MH \"Delegation of Authority\")1,524S18(MH \"Community Health Nursing+\")21,668S17S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16125,143S16TI ( \"primary care\" or \"primary healthcare\" or \"primary health care\" or primary W0 practice\* or general W0 practice\* or family W0 practice\* or outpatient\* or \"ambulatory care\" or \"community care\" or community W0 health\* or \"community medicine\" or \"home care\" ) OR AB ( \"primary care\" or \"primary healthcare\" or \"primary health care\" or primary W0 practice\* or general W0 practice\* or family W0 practice\* or outpatient\* or \"ambulatory care\" or \"community care\" or community W0 health\* or \"community medicine\" or \"home care\" )78,393S15(MH \"Home Health Care\")14,528S14(MH \"Community Medicine\")36S13(MH \"Community Health Services\")11,175S12(MH \"Ambulatory Care Facilities+\")8,574S11(MH \"Ambulatory Care\")6,117S10(MH \"Family Practice\")10,420S9(MH \"Primary Health Care\")30,073S8S5 OR S6 OR S7114,891S7TI ( physician\* or doctor or doctors or (general W0 practitioner\*) or GP or GPs or (family W0 practitioner\*) or \"conventional care\" or \"usual care\" or \"treatment as usual\" ) OR AB ( physician\* or doctor or doctors or (general W0 practitioner\*) or GP or GPs or (family W0 practitioner\*) or \"conventional care\" or \"usual care\" or \"treatment as usual\" )91,989S6(MH \"Physicians, Family\")8,240S5(MH \"Physicians\")31,958S4S1 OR S2 OR S3301,180S3TI ( nurse or nurses or midwife or midwives ) OR AB ( nurse or nurses or midwife or midwives )216,144S2(MH \"Midwives+\")8,346S1(MH \"Nurses+\")151,395

**Open Grey = 21 hits (27.02.2017)**

1. (\"nurse led\" OR \"nurse managed\" OR \"nurse run\" OR \"nurse delivered\") = 18 hits {#CD001271-sec3-0029}
=========================================================================================

2. (substitute OR substitution OR substituting) AND (nurse OR nurses) AND (doctor OR doctors OR physician OR physicians OR \"general practitioner\" OR \"general practitioners\") = 3 hits {#CD001271-sec3-0030}
==========================================================================================================================================================================================

Grey Literature Report = 97 hits (27.02.2017) {#CD001271-sec3-0031}
=============================================

The Grey Literature Report was searched on 27 February 2017 using different search terms:

1\. \"nurse practitioner\" = 14 hits

2\. \"nurse clinician\" = 1 hit

3\. \"nurse led\" = 6 hits

4\. \"nurse managed\" = 65 hits

6\. \"nurse delivered\" = 11 hits

7\. substitut ‐ with Additional Keywords: doctor = 0 hits

8\. substitut ‐ with Additional Keywords: physician = 0 hits

9\. substitut ‐ with Additional Keywords: \"general practitioner\" = 0 hits

**International Clinical Trials Registry Platform (ICTRP), Word Health Organization (WHO**): [www.who.int/ictrp/en/](www.who.int/ictrp/en/)**= 71 hits (21.02.2017)**

1\. Advanced search: nurse led OR nurse managed OR nurse run OR nurse delivered \[in Title + Recruitment status: All\]

OR

nurse led OR nurse managed OR nurse run OR nurse delivered \[in Intervention + Recruitment status: All\]

2\. Advanced search: substitut\* AND nurse\* AND (doctor\* OR physician\* OR general practitioner OR general practitioners) \[in Title + Recruitment status: All\]

OR

substitut\* AND nurse\* AND (doctor\* OR physician\* OR general practitioner OR general practitioners) \[in Intervention + Recruitment status: All\]

**ClinicalTrials.gov, US National Institutes of Health (NIH):**[clinicaltrials.gov/](clinicaltrials.gov/)**= 172 hits (21.02.2017)**

1\. Search Terms: \"nurse led\" OR \"nurse managed\" OR \"nurse run\" OR \"nurse delivered\"

2\. Search Terms: (substitute OR substitution OR substituting) AND (nurse OR nurses) AND (doctor OR doctors OR physician OR physicians OR \"general practitioner\" OR \"general practitioners\")

**Science Citation Index and the Social Sciences Citation Index, Web of Science, Thomson Reuters = 41 hits (2015)**

Citation search for the following studies: Campbell 2014; Houweling 2011; Iglesias 2013; Larsson 2014; Ndosi 2014

**Assessing the certainty** \[1\]**of evidence across studies for an outcome**

**Comparison nurse ‐ doctor substitution in primary care**

***Certainty assessment of evidence for each outcome***

**No of studiesDesignRisk of biasInconsistencyIndirectness ^\[2\]^ImprecisionOther ^\[3\]^Certainty**\
**(overall score) ^\[4\]^Outcome: mortality**8Randomised trialsNo serious risk of biasThe trials contributing to this estimate are quite varied (some focus on people with specific health issues and others on more generalist primary care attenders (‐1)No serious indirectnessWide CI that includes no effect (‐1)NoneLow (3)**Outcome: patient health status**Clinical outcomes (3)\
Self‐reported measurements (13)Randomised trialsNo serious risk of biasSome studies: effect varies between trials (‐0.5)No serious indirectnessSome studies: wide CI (‐0.5)NoneModerate (3)Outcome: physical function3Randomised trialsNo serious risk of biasEffect varies between trials.\
(‐1)No serious indirectnessNo serious imprecisionNoneModerrate (3)Outcome: pain2Randomised trialsNo serious risk of biasNo serious inconsistencyOnly patients with rheumatoid arthritis were included (‐1).No serious imprecisionNoneModerate (3)Outcome: systolic blood pressure3Randomised trialsHigh risk of bias in 1 out of 3 studies (‐1)No serious inconsistencyNo serious indirectnessNo serious imprecisionNoneModerate (3)Outcome: diastolic blood pressure2Randomised trialsHigh risk of bias in 1 out of 2 studies (‐1)No serious inconsistencyNo serious indirectnessNo serious imprecisionNoneModerate (3)Outcome: total cholesterol2Randomised trialsNo serious risk of biasNo serious inconsistencyNo serious indirectnessNo serious imprecisionNoneHigh (4)Outcome: HbA1C2Randomised trialsHigh risk of bias in 1 out of 2 studies (‐1)No serious inconsistencyNo serious indirectnessNo serious imprecisionNoneModerate (3)Outcome: DAS2Randomised trialsNo serious risk of biasNo serious inconsistencyOnly patients with rheumatoid arthritis were included. (‐1)No serious imprecisionNoneModerate (3)**Outcome: satisfaction and preference**7Randomised trialsNo serious risk of biasImportant heterogeneity (‐1)No serious indirectnessNo serious imprecisionNoneModerate (3)**Outcome: quality of life**6Randomised trialsNo serious risk of biasImportant heterogeneity (‐1)No serious indirectnessWide CI that includes no effect (‐1)NoneLow (2)**Outcome: process of care ‐** no GRADE due to no pooled analyses and a wide range of outcomes**Outcome: utilisation**19Randomised trialsNo serious risk of biasSome outcomes: important heterogeneity and effects that vary between trials (‐0.5)No serious indirectnessSome outcomes: Wide CI (‐0.5)NoneModerate (3)Outcome: length of consultation4Randomised trialsNo serious risk of biasImportant heterogeneity (‐1)No serious indirectnessNo serious imprecisionNoneModerate (3)Outcome scheduled: return visits3Randomised trialsNo serious risk of biasImportant heterogeneity (‐1)No serious indirectnessWide CI (‐1)NoneLow (2)Outcome: attended return visits4Randomised trialsNo serious risk of biasNo serious inconsistencyNo serious indirectnessNo serious imprecisionNoneHigh (4)Outcome: prescriptions ordered4Randomised trialsNo serious risk of biasNo serious inconsistencyNo serious indirectnessNo serious imprecisionNoneHigh (4)Outcome: investigations4Randomised trialsNo serious risk of biasImportant heterogeneity (‐1)No serious indirectnessWide CI (‐1)NoneLow (2)Outcome: hospital referral5Randomised trialsNo serious risk of biasImportant heterogeneity (‐1)No serious indirectnessWide CI (‐1)NoneLow (2)Outcome: attendance at A&E6Randomised trialsNo serious risk of biasNo serious inconsistencyNo serious indirectnessNo serious imprecisionNoneHigh (4)Outcome: hospital admission3Randomised trialsHigh risk of bias in 1 out of 3 studies (‐1).No serious inconsistencyNo serious indirectnessWide CI (‐1)NoneLow (2)**Outcome: costs ‐** no grade since the types of costs assessed varied widely and a range of different approaches were used to value resources and calculate costs

\[1\] This can also be referred to as 'quality of the evidence' or 'confidence in the estimate'. The "certainty of the evidence" is an assessment of how good an indication the research provides of the likely effect; i.e. the likelihood that the effect will be substantially different from what the research found. By "substantially different", we mean a large enough difference that it might affect a decision.

\[2\] Indirectness includes consideration of:

· Indirect (between‐study) comparisons

· Indirect (surrogate) outcomes

· Applicability (study populations, interventions, or comparisons that are different from those of interest).

\[3\] Other considerations for downgrading include publication bias. Other considerations for upgrading include a strong association with no plausible confounders, a dose response relationship, and if all plausible confounders or biases would decrease the size of the effect (if there is evidence of an effect), or increase it if there is evidence of no harmful effect (safety).

\[4\]

4 **High** = This research provides a very good indication of the likely effect. The likelihood that the effect will be substantially different\*\* is low.

3 **Moderate** = This research provides a good indication of the likely effect. The likelihood that the effect will be substantially different\*\* is moderate.

2 **Low** = This research provides some indication of the likely effect. However, the likelihood that it will be substantially different\*\* is high.

1 **Very low** = This research does not provide a reliable indication of the likely effect. The likelihood that the effect will be substantially different\*\* is very high.

\*\* Substantially different = a large enough difference that it might affect a decision.

Comparison 1Doctor‐nurse substitution study resultsOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Mortality](#CD001271-fig-00101){ref-type="fig"}Analysis 1.1Comparison 1 Doctor‐nurse substitution study results, Outcome 1 Mortality.836529Risk Ratio (IV, Random, 95% CI)0.77 \[0.57, 1.03\][2 Physical function (better vs not better)](#CD001271-fig-00102){ref-type="fig"}Analysis 1.2Comparison 1 Doctor‐nurse substitution study results, Outcome 2 Physical function (better vs not better).33549Risk Ratio (Random, 95% CI)1.03 \[0.98, 1.09\][3 Pain](#CD001271-fig-00103){ref-type="fig"}Analysis 1.3Comparison 1 Doctor‐nurse substitution study results, Outcome 3 Pain.2Mean Difference (Random, 95% CI)0.76 \[‐3.85, 5.38\][4 Quality of life](#CD001271-fig-00104){ref-type="fig"}Analysis 1.4Comparison 1 Doctor‐nurse substitution study results, Outcome 4 Quality of life.616002Std. Mean Difference (Random, 95% CI)0.16 \[0.00, 0.31\][5 Systolic blood pressure](#CD001271-fig-00105){ref-type="fig"}Analysis 1.5Comparison 1 Doctor‐nurse substitution study results, Outcome 5 Systolic blood pressure.31023Mean Difference (IV, Random, 95% CI)‐3.73 \[‐6.02, ‐1.44\][6 Diastolic blood pressure](#CD001271-fig-00106){ref-type="fig"}Analysis 1.6Comparison 1 Doctor‐nurse substitution study results, Outcome 6 Diastolic blood pressure.2562Mean Difference (IV, Random, 95% CI)‐2.54 \[‐4.57, ‐0.52\][7 Total cholesterol](#CD001271-fig-00107){ref-type="fig"}Analysis 1.7Comparison 1 Doctor‐nurse substitution study results, Outcome 7 Total cholesterol.2702Mean Difference (IV, Random, 95% CI)‐0.15 \[‐0.32, 0.02\][8 HbA1c](#CD001271-fig-00108){ref-type="fig"}Analysis 1.8Comparison 1 Doctor‐nurse substitution study results, Outcome 8 HbA1c.2310Mean Difference (IV, Random, 95% CI)0.08 \[‐0.25, 0.41\][9 Disease Activity Score](#CD001271-fig-00109){ref-type="fig"}Analysis 1.9Comparison 1 Doctor‐nurse substitution study results, Outcome 9 Disease Activity Score.2Mean Difference (Random, 95% CI)0.04 \[‐0.17, 0.24\][10 Patient satisfaction](#CD001271-fig-00110){ref-type="fig"}Analysis 1.10Comparison 1 Doctor‐nurse substitution study results, Outcome 10 Patient satisfaction.716993Std. Mean Difference (Random, 95% CI)0.08 \[0.01, 0.15\][11 Length of consultation](#CD001271-fig-00111){ref-type="fig"}Analysis 1.11Comparison 1 Doctor‐nurse substitution study results, Outcome 11 Length of consultation.45848Std. Mean Difference (Random, 95% CI)0.38 \[0.22, 0.54\][12 Scheduled return visits](#CD001271-fig-00112){ref-type="fig"}Analysis 1.12Comparison 1 Doctor‐nurse substitution study results, Outcome 12 Scheduled return visits.33934Risk Ratio (Random, 95% CI)1.31 \[0.89, 1.94\][13 Attended return visit](#CD001271-fig-00113){ref-type="fig"}Analysis 1.13Comparison 1 Doctor‐nurse substitution study results, Outcome 13 Attended return visit.45064Risk Ratio (Random, 95% CI)1.19 \[1.07, 1.33\][14 Prescription ordered](#CD001271-fig-00114){ref-type="fig"}Analysis 1.14Comparison 1 Doctor‐nurse substitution study results, Outcome 14 Prescription ordered.45702Risk Ratio (Random, 95% CI)0.99 \[0.95, 1.03\][15 Investigations](#CD001271-fig-00115){ref-type="fig"}Analysis 1.15Comparison 1 Doctor‐nurse substitution study results, Outcome 15 Investigations.43654Risk Ratio (Random, 95% CI)0.95 \[0.59, 1.51\][16 Hospital referral](#CD001271-fig-00116){ref-type="fig"}Analysis 1.16Comparison 1 Doctor‐nurse substitution study results, Outcome 16 Hospital referral.417299Risk Ratio (Random, 95% CI)0.90 \[0.54, 1.49\][17 Attendance at accident and emergency](#CD001271-fig-00117){ref-type="fig"}Analysis 1.17Comparison 1 Doctor‐nurse substitution study results, Outcome 17 Attendance at accident and emergency.629905Risk Ratio (Random, 95% CI)1.00 \[0.91, 1.09\][18 Hospital admission](#CD001271-fig-00118){ref-type="fig"}Analysis 1.18Comparison 1 Doctor‐nurse substitution study results, Outcome 18 Hospital admission.316466Risk Ratio (Random, 95% CI)1.04 \[0.78, 1.39\]

Last assessed as up‐to‐date: 15 January 2015.

**DateEventDescription**26 April 2017New citation required but conclusions have not changedThis update includes nine new studies. The total number of included studies in the review is now 18. New review authors have contributed to this update. We have excluded from this update seven studies previously included in the review (3 controlled before‐after studies, 3 non‐randomised trials, and 1 study focussing on mental health problems).26 April 2017New search has been performedThis is the first update of the Cochrane review published in 2005. We have conducted a new search and have updated other content. We updated the search in March 2017 and added one trial report to 'Studies awaiting classification'.

Protocol first published: Issue 4, 1998 Review first published: Issue 2, 2005

**DateEventDescription**16 July 2004New citation required and conclusions have changedWe have made substantive amendments.

Because of the large number of available randomised trials, we excluded non‐randomised trials from this review ([@CD001271-bbs2-0078]).

In the next update, we will consider again (1) including subgroup analyses on differently trained nurses related to the level of training of participating nurses; and (2) pooling cost data from studies that reported costs.

We performed no statistical testing for funnel plot asymmetry, as none of the pooled outcomes included more than 10 studies. If more than 10 studies would be included, we will follow the recommendations provided in the *Cochrane Handbook for Systematic Reviews of Interventions* ([Chapter 10.4.3.1.](Chapter 10.4.3.1.)).

**Change in authorship:** We have added Anneke van Vught, Mieken van der Biezen, Nancy Wijers, Kanokwaroon Watananirun, and Evangelos Kontopantelis to the review author list. We have removed D. Reeves, R. Hermes, J. Braspenning, R. Grol, and B. Sibbald from the list of review authors (see [Acknowledgements](#CD001271-sec1-0010){ref-type="ack"}).

Characteristics of included studies \[ordered by study ID\] {#CD001271-sec2-0020}
===========================================================

[@CD001271-bbs2-0001]MethodsRandomised trialParticipants13,707 patients (total group); mean age in intervention group 41.5 (25.2), in control group 44.7 (25.0); 40% male in intervention group, 41% male in control group\
42 practices at 4 centresInterventions**Intervention:** nurse‐led computer‐supported telephone triage\
**Control:** GP‐led telephone triage\
**Detailed description of the intervention:**\
Compared 3 groups delivering telephone triage: GP‐led triage, nurse‐led computer‐based triage, and usual care triage\
*GP‐led*: Components of the Stour Access System were used. Once the receptionist had established that the patient was requesting a same‐day appointment, the patient was asked to leave a contact number with the receptionist and was advised that the GP would call the patient back within around 1 to 2 hours. This time scale (for both GP‐led and nurse‐led arms) was flexible, so as to optimise prioritisation. The GP discussed the complaint with the patient and triaged the patient to the most appropriate person, such as a nurse, or booked a face‐to‐face appointment with the GP, or provided advice on the telephone*Nurse‐led*: The Plain Healthcare Odyssey Patient Access System was used for patients registered at the practice. A computerised clinical decision support (CCDS) system was used to assist nurses at the practice in assessing and making decisions about the clinical needs of patients who have called the practice requesting a same‐day appointment*Usual care*: Standard consultation management system practices were used (differed between practices)\
**Supervision, oversight:** unknownOutcomes**Patient outcomes:**\
Patients\' experience of care after the same‐day requestProblem resolutionOverall satisfaction with care provided on the day of the consultation requestHealth status (EQ‐5D)Deaths associated with trial processes\
**Process of care measures:**\
Primary care workload (total numbers of primary care contacts taking place in the 28 days after the patient's index appointment request)Occurrences of each of the 20 individual consultation types contributing to the primary outcomeProfile of patient contacts and their distribution by healthcare professionalsPatient safety (i.e. the occurrence and duration of any emergency hospital admissions within 7 days of the index request, and the number of patients with any attendances at accident and emergency departments within 28 days)\
**Resource utilisation:**\
**Costs:** costs over 28 days with regard to primary outcome contactsNotes**Country:** UK\
**Study period:** 25 months\
**Nurse role:** nurse in charge of computer‐supported telephone triage for patients requesting a same‐day appointment\
**Nurse title:** nurse (nurse practitioners and practice nurses)\
**Nurse educational background:** EQF level unknown\
**Nurse years of experience:** unknown\
**Nurse additional training:** training in the use of Odyssey Patient Access and in telephone consultation skills. Following this was a pretrial period of 1 month, during which nurses were expected to practise using the decision support in their daily work; towards the end of this period, their use of the system was assessed***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskThe sequence process included a random component.\
\"Participating practices were randomly assigned (1:1:1), via a computer‐generated randomisation sequence, to GP triage, nurse triage with computer decision support, or usual care. The randomisation sequence \[was\] minimized for research centre, deprivation (deprived \[below average Index of Multiple Deprivation 2010, based on practice postcode\] or not‐deprived \[average or above\]) and list size (small \[\< 3500 patients\], medium \[3500--8000 patients\], or large \[\> 8000 patients\]) of the trial team\".\
However, 10 of the 15 practices allocated to NP triage withdrew.\
\"To maintain balance between groups, any practices that withdrew after randomisation were replaced with a waiting‐list practice that was from the same location, and of similar size and deprivation when possible. Because of the small numbers of waiting‐list practices, replacements were purposively allocated according to minimisation criteria\".Allocation concealment (selection bias)Low riskPatients and investigators enrolling patients could not foresee assignment.\
\"A stochastic element within the minimisation algorithm maintained concealment. Allocation was done by a statistician independent form\".\
\"Allocations were concealed from practices until after they had agreed to participate; this concealment also applied to practices replacing practices that had withdrawn from the study for whatever reason\".Baseline characteristicsLow riskCharacteristics of patients were similar in both groups. \"Practice and patient characteristics were well balanced between groups\".Baseline outcome measurementLow riskBaseline primary outcome measurement was not relevant. Baseline secondary outcome health status was not measured, and differences in baseline health status could bias the outcome 'health status'.Blinding of participants and personnel (performance bias) All outcomesUnclear riskPractitioners and patients were not blinded. It is unclear whether the outcome was influenced by lack of blinding of patients and care providers.\
\"Patients, clinicians, and researchers were not masked to allocation, but practice assignment was concealed from the trial statistician\".Blinding of outcome assessment (detection bias) All outcomesUnclear riskResearchers were not blinded; however, the trial statistician was blinded.\
\"Patients, clinicians, and researchers were not masked to allocation, but practice assignment was concealed from the trial statistician\".Incomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \< 80%; however per‐protocol and intention‐to‐treat analyses showed similar results.\
\"Findings from our per‐protocol analysis showed intensification of the noted effects of both GP triage and nurse triage (data not shown)\".Selective reporting (reporting bias)Low riskProtocol was available. Predefined outcomes measurements were reported.ContaminationLow riskNot likely, because allocation was by practiceBias due to lack of powerLow risk\"7046 patients per group would need to be recruited from 42 practices\".\
In the GP triage, 6781 patients were eligible for intervention (6697 + 84). This is a relatively small difference with the calculated power.\
Trial authors commented: \"The trial was fully powered and we exceeded our recruitment target in gaining access to the primary outcome data, partly because of a process of obtaining initial verbal consent to participate\".[@CD001271-bbs2-0002]MethodsRandomised trialParticipants868 patients (total group), all ages, 34% male 1 nurse 1 doctorInterventions**Intervention:** families allocated to nurse‐led primary care **Control:** families allocated to doctor‐led primary care\
**Detailed description of the intervention:**\
Compared 2 groups providing family care:\
A conventional group, assigned to continuing primary clinical services from a family doctorA family practice nurse group whose first contact primary clinical services were to be provided by the family practice nurse\
**Supervision, oversight:** The family practice nurse was delegated the responsibility of choosing between three possible courses of action: providing specific treatment; providing reassurance alone, without specific treatment; or referring the patient to the associated family doctor, to another clinician, or to an appropriate service agency.Outcomes**Patient outcomes:**\
Health statusNotes**Country:** Canada\
**Study period:** 12 months\
**Nurse role:** first contact and ongoing primary care\
**Nurse title:** practice nurse\
**Nurse educational background:** EQF level unknown\
**Nurse years of experience:** The nurse already worked for 4 years in the family practice.\
**Nurse additional training:** The nurse attended a special 9‐month education programme for family practice nurses including skills such as decision‐making, clinical judgement, social history taking, physical examinations, and the ability to distinguish between abnormal and normal patient symptoms and signs.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskNo clear method of randomisation was reported. \"Random allocation in a ratio of 2:1\" (family doctor:family practice nurse)Allocation concealment (selection bias)Unclear riskNo informationBaseline characteristicsLow riskBaseline characteristics were reported and were similar for both groups.\
\"The groups are highly similar and none of the observed differences are statistically significant\".Baseline outcome measurementLow riskBaseline outcomes were reported and were similar for both groups.Blinding of participants and personnel (performance bias) All outcomesUnclear riskFamilies/patients and care providers were not blinded. It is unclear whether the outcome was influenced by lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesUnclear riskNo informationIncomplete outcome data (attrition bias) All outcomesHigh riskFollow‐up of patients \< 80% (\"65.5%\")Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationUnclear riskNo informationBias due to lack of powerUnclear riskNo power calculation performed[@CD001271-bbs2-0003]MethodsRandomised trialParticipants175 patients (total group), mean age 48.4 years (control), 50.2 years (intervention); 49% male (in total)\
1 nurse and unknown number of doctorsInterventions**Intervention:** patient care after gastric endoscopy allocated to nurse\
**Control:** patient care after gastric endoscopy allocated to doctor\
**Detailed description of the intervention:**\
Compared 2 groups providing follow‐up for patients with dyspepsia after direct access gastroscopy.\
Systematic GNP‐led follow‐up in an out‐patient clinic: The \'GNP\' group was given 1 out‐patient appointment; a full medical history was taken.Usual care by GPs: The \'GP\' cohort was discharged and was advised to see their GP.\
Patients included were those with mild gastroesophageal reflux disease (GORD -- non‐erosive or grade A and B oesophagitis, hiatus hernia), those with non‐ulcer dyspepsia (NUD) (mild and moderate gastritis or duodenitis), and those with normal findings. After gastroscopy, endoscopists maintained their routine practice in giving verbal and written advice to patients and documented treatment recommendations to GPs in a formal report. Clinical management was structured, based on national and local guidelines, with reference to each patient\'s predominant symptoms. Patients were given counselling and lifestyle advice, supplemented with relevant locally devised leaflets (i.e. reflux, non‐ulcer dyspepsia, weight control), and an individualised treatment plan was agreed upon. Further investigation such as the urea breath test, motility studies, and barium meal were initiated, if required, as per routine clinical practice. To ensure practice consistency and reproducibility, \'history taking\' and \'lifestyle advice\' proformas were devised and used.\
**Supervision, oversight:** Studied interventional patients were seen in the nurse‐led clinic within secondary care, without direct supervision from any consultant gastroenterologists. However, cases could be discussed with a doctor, if deemed necessary.Outcomes**Patient outcomes:**\
Gladys, health status short form (SF‐12)Notes**Country:** UK\
**Study period:** 6 months\
**Nurse role:** ongoing care (follow‐up) after gastroendoscopy\
**Nurse title:** gastrointestinal nurse practitioner\
**Nurse educational background:** EQF level 8\
**Nurse years of experience:** The nurse had been qualified as a State Registered Nurse for 20 years and specialised in gastro nursing for 4 years and 2 months.\
**Nurse additional training:** Clinic consultation skill was developed with the help of a named GI consultant. Initially, the nurse sat in that clinic (2 months) as an observer. The next stage was to see patients who had been filtered by the consultant from that clinic on that day. The nurses' consulting room was next to the GI consultants' room to effect direct supervision, as each patient case was presented to the GI and treatment identified (6 months). Finally, a nurse‐led clinic was established and was formally running alongside the GI clinics, with pre‐identified patients advanced from all GI consultants. Some 18 months later, the nurse was authorised to discuss selective cases with the patient's named consultant, if required. Three monthly reviews were performed initially; this was reduced to yearly and was incorporated in the annual appraisal.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskThe sequence process included a random component.\
\"Patients eligible for entry after endoscopy were randomised into intervention (GNP) and control (GP) groups, with a password protected, computer generated random number table".Allocation concealment (selection bias)Low riskParticipants and investigators enrolling participants could not foresee assignment. \"with a password protected, computer generated random number table\"Baseline characteristicsLow riskBaseline characteristics were reported and were similar for both groups.\
\"The baseline Gladys scores (high scores equal higher burden of disease and symptoms) were similar (10.0 vs 9.9) but the SF12 scores (672.0 vs 627.7) were higher (high scores equal better health) in the GP group (see Table 1). The cost of UHD used, 6 months prior to the investigation, was lower in the GP group\
(£52.4 vs £59.5)\".\
But, \"The two groups were compared by the change from baseline to month 6 in the key outcome variables -- Gladys score, SF12 and overall UHDs cost, adjusted for baseline values by including the baseline levels of the outcome in the ANOVA as a covariate; p \< 0.05 was taken as being significant\".Baseline outcome measurementLow riskBaseline outcome measurements were reported and adjusted analyses performed. \"Adjusted for baseline level using ANOVA\"Blinding of participants and personnel (performance bias) All outcomesUnclear riskNo informationBlinding of outcome assessment (detection bias) All outcomesLow riskBlinding of assessment was performed.\
\"A researcher blinded to the patients\' study status and diagnosis interviewed all participants by telephone, at a prearranged time suitable to the patient, six months after randomisation\".Incomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80%\
\"199 unselected patients were approached and 196 (98.5%) were recruited. One hundred and seventy five (89.3%) patients were eligible after investigation. Of the 21 ineligible patients, 16 did not meet the criteria (Barrett\'s oesophagus: 6, oesophagitis grade C: 2, oesophageal stricture: 1, peptic ulcer disease: 3, possible cancer: 1). Three cases were deemed unsuitable by the endoscopist, as symptoms were attributed to other conditions (rhinitis 1, angina 2)\". Two did not have the procedure (failed intubation 1, food in stomach 1).\
\"Early withdrawals (GP n = 3, GNP n = 4) after randomisation were experienced in both groups (Figure 1). Three in the \'GP\' group decided not to see their GP. The four in the GNP group were due to work commitments (2), leaving the area (1) and after own GP consultation (1)\".Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationLow riskPatients in the intervention group went to a nurse‐led clinic, and controls went to their doctor. Therefore, it is unlikely that both groups were contaminated.Bias due to lack of powerLow riskNumber of included patients was approximately similar to results of the sample size calculation.[@CD001271-bbs2-0004]MethodsRandomised trialParticipants1501 patients (total group); mean age in intervention group 46.1, in control group 42.8; 38.2% male in intervention group, 40% male in control group\
50 GPs\
12 NPsInterventions**Intervention:** patients allocated to nurse practitioners\
**Control:** patients allocated to GPs\
**Detailed description of the intervention:**\
Compared 2 groups providing care to patients with common complaints as first point of contact\
The NP saw patients with respiratory and throat problems, ear and nose problems, musculoskeletal problems and injuries, skin injuries, urinary problems, gynaecological problems, and geriatric problems. The role of the NP involved assessing symptoms including physical examinations when appropriate and diagnosing and making decisions about further treatment, including writing prescriptions and referrals to primary or secondary services and clinical investigations.\
**Supervision, oversight:** The NP did not have full authority to prescribe medications, and so the GP was always available for consultation and for validation of prescriptions and referrals.Outcomes**Patient outcomes:**\
SatisfactionBurden of illnessQuality of life\
**Process of care measures:**\
Adherence to clinical guidelinesAppropriate medication prescribed\
**Resource utilisation:**\
PrescriptionsInvestigationsReturn visits\
**Costs:** direct healthcare costs, including and excluding productivityNotes**Country:** Netherlands\
**Study period:** 6 months\
**Nurse role:** first contact and ongoing care\
**Nurse title:** nurse practitioners\
**Nurse educational background:** EQF level 7\
**Nurse years of experience:** 0 years as an NP, at least 2 years of experience as a registered nurse\
**Nurse additional training:** unknown***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskThe sequence process included a random component. \"Sequentially‐numbered sealed envelopes containing randomised assignments to the two groups were provided by an independent person. The codes were generated from random number tables\".Allocation concealment (selection bias)Low riskPatients and investigators enrolling patients could not foresee assignment. \"Sequentially‐numbered sealed envelopes containing randomised assignments to the two groups were provided by an independent person. The codes were generated from random number tables\"Baseline characteristicsLow riskBaseline outcomes were reported and were similar for both groups. Only age was different.\
\"Patients who returned all questionnaires were statistically significantly older (mean = 48Æ74, SD = 16Æ8) than those who did not (mean = 42Æ75, SD = 16Æ4; p \< 0Æ001). There were no statistically significant differences in gender and type of diagnosis between patients with or without complete data. No statistically significant differences were noted between patients in two groups in terms of other (chronic) diseases\".Baseline outcome measurementUnclear riskPrimary outcomes could not be assessed before the intervention.Blinding of participants and personnel (performance bias) All outcomesUnclear riskPatients and care providers were not blind to the intervention. It is unclear whether the outcome was influenced by lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesUnclear riskNo informationIncomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80%\
\"499 met one or more exclusion criteria, declined to participate, had no interest or were too ill\".\
\"58 patients who were allocated to the NP intervention group and 47 patients in the reference group did not attend the appointment they had booked or refused to participate because of being too ill or not having an interest\".Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationLow riskIt is unlikely that patients who visited the GP consulted the NP for the same question/problem, or vice versa. \"Patients in the intervention group who did see the GP were excluded from analysis (n = 43)\".Bias due to lack of powerUnclear riskNo power calculation performed[@CD001271-bbs2-0005]MethodsRandomised trialParticipants450 patients (total group), mean age 61 years, 98% male 9 nurses 45 doctorsInterventions**Intervention:** patients allocated to nurse‐led primary care **Control 1:** patients allocated to trainee doctors (2nd and 3rd year residents) **Control 2:** patients allocated to fully trained doctors (attending doctors)\
**Detailed description of the intervention:** not available\
**Supervision, oversight:** First‐year residents and newly graduated nurse practitioners were required to present every patient to the attending doctors during the first 6 months of their appointment, whereas the remainder of residents and nurse practitioners presented cases only when they believed it to be necessary.Outcomes**Resource utilisation:**\
Consultation rateTestsUse of other services ‐ hospital admissions, emergency department visits, specialty visitsNotes**Country:** USA\
**Study period:** 12 months\
**Nurse role:** first contact and ongoing primary care\
**Nurse title:** nurse practitioners\
**Nurse educational background:** EQF level unknown\
**Nurse years of experience:** unknown\
**Nurse additional training:** unknown***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskThe sequence process included a random component. \"Most patients were assigned to any available provider and these patients were then scheduled by a clerk on a computerized system for the net available appointment, regardless of the type of provider\" \"Our study sample makes use of this quasi random assignment\".Allocation concealment (selection bias)Low riskParticipants or investigators enrolling participants could not foresee assignments. A computerised system was used.Baseline characteristicsUnclear riskNo informationBaseline outcome measurementUnclear riskPrimary outcomes were not assessed before the intervention.Blinding of participants and personnel (performance bias) All outcomesLow riskPractitioners low risk, patients no information (unclear risk) \"The practitioners at the Baltimore VAMC were aware that a study of utilization patterns was being conducted, but did not know which patients were included\".Blinding of outcome assessment (detection bias) All outcomesUnclear riskNo informationIncomplete outcome data (attrition bias) All outcomesUnclear riskNo information available about follow‐upSelective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationUnclear riskNo information. However, the quote \"For the purposes of this study, patients remained in the group to which they were initially assigned, even if their type of primary care provider changed after the first visit\" suggests that contamination has occurred.Bias due to lack of powerUnclear riskNo power calculation performed[@CD001271-bbs2-0006]MethodsRandomised trialParticipants239 patients (total group); mean age in intervention group 67.1 (11.0), in control group 69.5 (10.6); 52.9% male in intervention group, 42.3% male in control group\
5 doctors (GPs)\
2 nursesInterventions**Intervention:** patients with T2DM allocated to nurse practitioners\
**Control:** patients with T2DM allocated to GPs\
**Detailed description of the intervention:**\
Compared 2 groups providing diabetes care:\
Treatment primarily by PNsStandard care from a GP\
Eligible patients were selected via the GPs' patient information system and the local pharmacy. Initial selection included patients with a diagnosis of diabetes, patients who were on medication for diabetes, and patients whose glycated haemoglobin (HbA1c) levels had been measured within the past 3 years. Exclusion criteria were (1) no diagnosis of diabetes, (2) type 1 diabetes, (3) diabetes not treated in the primary healthcare setting, (4) inability to participate in the study because of old age or comorbidity, in the opinion of the GP, and (5) not willing to return for follow‐up. PNs were permitted to prescribe 14 different medications and to adjust dosages for a further 30. They were also allowed to order laboratory tests. PNs specifically were not permitted to prescribe insulin but were able to adjust the dosage.\
**Supervision, oversight:** PNs worked with a protocol published in \"protocollaire diabeteszorg\". The protocol indicated when the PN had to consult the GP. In case the patient showed specific complaints during consultation, the patient would be referred to the GP.Outcomes**Patient outcomes:**\
HbA1c, BP, chol, chol/hdl, glycaemic controlBlood pressureLipid profileHRQOLDiabetes‐related symptomsPatients' satisfaction\
**Process of care measures:**\
Referred to an ophthalmologist after not having visited one for the past 2 years, by whom measures were taken for feet at‐riskReferred to an internist for starting insulin therapy, after diabetic, antihypertensive, and/or lipid‐lowering drugs had been intensified\
**Resource utilisation:**\
Health care consumption (number of patient visits, number of contacts between PNs and GP)Notes**Country:** Netherlands\
**Study period:** unknown\
**Nurse role:** ongoing care for patients with diabetes type 2 in a primary care setting\
**Nurse title:** practice nurse\
**Nurse educational background:** EQF level 5\
**Nurse years of experience:** 2 PNs, experienced in working as a nurse; however no prior experience working in general practice\
**Nurse additional training:** At the beginning of the trial, PNs received 1 week of training on a detailed treatment and management protocol aimed at optimising glucose, blood pressure, and lipid profile regulation and eye and foot care in patients with diabetes. Training aimed to educate PNs to a level comparable to the level of a GP, so they would be able to provide diabetes care without supervision.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskA random sequence was used; sequence generation was by odd/even number of closed envelopes.\
\"Patients willing to participate were then randomised by two independent medical investigators (STH and NK)...\... Subjects with even numbers were assigned to the intervention group, and those with odd numbers were assigned to the control group\".Allocation concealment (selection bias)Low riskAllocation was concealed using sequentially numbered closed envelopes\
\"The patient population was randomised using non‐transparent, closed envelopes containing sequential numbers\".Baseline characteristicsLow riskCharacteristics of patients were similar in both groups.\
\"The groups were comparable with respect to age, gender, T2DM duration, body mass index (BMI), blood pressure, HbA1c and lipid profile\".Baseline outcome measurementLow riskBaseline outcomes were reported and were similar for both groups, except feet at‐risk. One of the secondary outcomes was measures to prevent development of diabetic foot symptoms. The percentage of feet at‐risk cases was calculated. Therefore, we do not expect bias due to unsimilarity in baseline feet at‐risk.\
\"The groups were comparable with respect to age, gender, T2DM duration, body mass index (BMI), blood pressure, HbA1c and lipid profile. However, more patients in the PN group had feet at‐risk compared to the GP group\".Blinding of participants and personnel (performance bias) All outcomesUnclear riskIt is unclear whether the outcome was influenced by lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesUnclear riskNot performed. It is unclear whether the outcome was influenced by lack of blinding of the outcome assessment, because outcomes could not be easily influenced.\
\"The outcome assessors of the clinical variables (such as blood pressure) were not blinded to the\
intervention\".Incomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80%Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationUnclear riskAllocation was by patient. Only 1 practice was involved. Not reported whether trial authors protect against contaminationBias due to lack of powerUnclear riskLack of power, according to the power calculation. If this really was biased, the outcome was unclear. However, trial authors discussed the following:\
\"the required sample size to detect a 0Æ5%‐point difference in HbA1c was a total of 216 patients. Unfortunately, we only have a complete follow‐up of 206 patients. However, the difference in HbA1c ( confidence interval) between groups after 14 months was 0Æ042% (0Æ207;0Æ265). As the confidence interval does not include the possibility of a 0Æ5%‐point difference in HbA1c between groups, we are able to make the conclusions as hypothesised\".[@CD001271-bbs2-0007]MethodsRandomised trialParticipants1461 patients (total group), 708 control, 753 intervention; mean age in intervention group 39.0 (15.1), in control group 38.6 (14.5); 39.0% male in intervention group, 38.8% male in control group\
142 GPs\
155 nursesInterventions**Intervention:** care delivered by nurses to patients asking same‐day appointment\
**Control:** usual care delivered by GPs to patients asking same‐day appointment\
**Detailed description of the intervention:**\
Compared effectiveness of care delivered by nurses vs usual care delivered by GPs, in adult patients asking to be seen on the same day in primary care practices. Patients assigned to the intervention group were seen by trained nurses, who followed guidelines developed during the study\'s preparation phase. Nurses had access to an electronic application, which included the guidelines, designed as a decision‐making support tool. Patients assigned to the control group were seen by the GP, who followed the usual procedures established in the practice and did not have access to any kind of decision‐making support tools.\
**Supervision, oversight:** unknownOutcomes**Patient outcomes:**\
Resolution of symptomsPatient satisfactionPatient perception of the quality of information and care receivedPatient preference\
**Process of care measures:**\
Resolution by nurseDuration of the visit\
**Resource utilisation:**\
Drug prescriptionsSick leaveRe‐visit in primary care for the same reason during the following 2 weeksAdmission to hospital for the same reasonNotes**Country:** Spain\
**Study period:** 5 months\
**Nurse role:** nurses trained to respond to low‐complexity, acute pathologies\
**Nurse title:** nurse\
**Nurse educational background:** EQF level unknown\
**Nurse years of experience:** unknown\
**Nurse additional training:** unknown***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskThe sequence process included a random component.\
\"Participants were randomly assigned following simple randomisation procedures to intervention or control using an automatic probabilistic function which assigns one group or another using a probability of 0.5. Patients were recruited consecutively until the necessary number of subjects was obtained, ensuring a balanced allocation of groups\".Allocation concealment (selection bias)Low riskPatients and investigators enrolling patients could not foresee assignment.\
\"The application was used to implement the random allocation\
sequence. The sequence was concealed until groups\
were assigned because the application generated the\
sequence just after the patient gave oral and written consent to participate in the study\".Baseline characteristicsLow riskCharacteristics of patients were similar in both groups.Baseline outcome measurementUnclear riskOutcome patient preference was not assessed before the intervention.Blinding of participants and personnel (performance bias) All outcomesUnclear riskIt is unclear whether the outcome was influenced by lack of blinding of patients and care providers.\
\"Participants, nurses and GPs where not blinded to group assignment\".Blinding of outcome assessment (detection bias) All outcomesLow riskOutcome assessors were blind. \"The administrative staff member, who phoned the patients 15 days later to the first visit, where blinded to group assignment\".Incomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80% \"Of the 1,461 randomised patients, 1,351 (92.5%) completed the study\".Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationUnclear riskOne of the outcomes was 'level of resolution by nurses'. It is unclear what happened in the analysis with patients seen by both groups, owing to non‐resolution by nurses.Bias due to lack of powerLow riskSufficient power\
\"...obtaining a final sample size of 1,340 patients (670 per group)\"[@CD001271-bbs2-0008]MethodsRandomised trialParticipants107 patients (total group). Mean age in intervention group 55.0 (12.3), in control group 55.8 (13.2); 45.0% male in intervention group, 44% male in control group\
5 nurses\
Unknown number of rheumatologistsInterventions**Intervention:** patients monitored by a nurse, later monitored by a rheumatologist\
**Control:** patients monitored by a rheumatologist\
**Detailed description of the intervention:**\
Compared and evaluated treatment outcomes at a nurse‐led rheumatology clinic and a rheumatologist‐led clinic in patients with low disease activity or in remission undergoing biological therapy. The intention was to replace one of the 2 annual rheumatologist monitoring visits by a nurse‐led rheumatology monitoring visit in patients undergoing biological therapy.\
**Rheumatologist‐led clinic:** Patients with CIA undergoing biological therapy were monitored by a rheumatologist every 6 months for 30 minutes to evaluate effects of the medication and to measure disease activity. The rheumatologist assessed disease activity by examining tender and swollen joints based on a 28‐joint count in addition to evaluating the results of laboratory tests.**Nurse‐led rheumatology clinic:** Patients were monitored for 30 minutes by a rheumatology nurse after 6 months*,* then for 30 minutes by a rheumatologist after 12 months. The nurse assessed patients\' disease activity by examining tender and swollen joints based on the 28‐joint count in addition to evaluating results of laboratory tests in the same way as a rheumatologist. Drug treatment was discussed in terms of administration, adherence, side effects, and laboratory tests, as well as patients\' global health.\
**Supervision, oversight:** If necessary, the nurse could contact the rheumatologist to ask for advice or to obtain a prescription.Outcomes**Patient outcomes:**\
Disease activityPerceived global health the previous weekPhysical difficulties in performing activities of daily livingPainSatisfaction with and confidence in obtaining rheumatology careMedication recordEmployment statusAdverse events\
**Resouce utilisation:**\
Cortisone injections in addition to regular rheumatologist monitoring visitsBlood testsRadiographyPharmacological therapyAdditional telephone calls to a rheumatology nurseAdditional telephone calls to a rheumatologistAdditional rheumatologist visitsTeam rehabilitation in in‐patient settingsTeam rehabilitation in out‐patient settingsOccupational therapist treatmentsPsychosocial treatmentsSpecialist consultations\
**Costs:** total annual rheumatology care per patientNotes**Country:** Sweden\
**Study period:** 22 months\
**Nurse role:** nurse‐led rheumatology monitoring visit for patients undergoing biological therapy\
**Nurse title:** registered nurse\
**Nurse educational background:** EQF level 6\
**Nurse years of experience:** 22 to 39 years\' professional experience and 9 to 20 years\' experience managing rheumatic diseases in both in‐patient and out‐patient rheumatology care\
**Nurse additional training:**\
Nurses had undergone special training provided by a rheumatologist and RA instructors to assess swollen and tender joints based on the 28‐joint count to make an evidence‐based assessment of disease activity.\
• Theoretical lecture about anatomy of the joint with pictures and about joint examination techniques -- inspection, palpation, assessing range of motion and function for a half hour\
• Practical examination of the hand and wrist.\
Nurses were trained in groups of 2 to 3 by RA instructors (patient partners) who had RA themselves and were well educated. Time: 1.5 hours\
• Same procedure, but now foot and ankle. Time: 1.5 hours\
• All nurses also got a booklet about hand and wrist examination, and another about foot and ankle examination, for self‐study and training.\
• One week later, another 1.5‐hour lecture to repeat both hand and foot examinations in the same groups\
• Rheumatologist met the whole group of nurses and gave a lecture on how to examine the big joints ‐ shoulder, elbow, knee, and hip. Nurses examined an RA patient and then practiced on each other. Time: 1.5 hours\
• Time to ask the rheumatologist questions afterwards if needed, and to watch the rheumatologist examining other patients in the practice***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskThe sequence process included a random component.\
\"Randomization took the form of sealed envelopes containing assignment to one of the two groups. The envelopes were mixed and when a patient met the inclusion criteria, an envelope was randomly picked\".Allocation concealment (selection bias)Low riskPatients and investigators enrolling patients could not foresee assignment.\
\"Randomization took the form of sealed envelopes containing assignment to one of the two groups. The envelopes were mixed and when a patient met the inclusion criteria, an envelope was randomly picked\".Baseline characteristicsUnclear riskCharacteristics of patients were similar in both groups, except in those with rheumatic disease. It is unclear whether this biased trial results.Baseline outcome measurementLow riskPrimary outcomes were assessed before the intervention. Mean differences were used as an outcome.Blinding of participants and personnel (performance bias) All outcomesUnclear riskNo information available It is unclear whether the outcome was influenced by possible lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesHigh riskNot performed It is unclear whether the outcome was influenced by lack of blinding of the outcome assessment. Assessment of disease activity may have been influenced by lack of blinding of the outcome assessor.\
\"The monitoring by the rheumatology nurse (intervention group) and the rheumatologist (control group) included an assessment of the number of swollen and tender joints based on the DAS28\".\
and\
\"All patients were monitored by the rheumatologist at baseline\
and after 12 months\".Incomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80%\
\"In total, 47 patients (89%) in the intervention group and 50 patients (93%) in the control group completed the 12‐month trial\".Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationUnclear riskNot reported whether trial authors protect against contaminationBias due to lack of powerLow riskSufficient power\
\"Based on a change of 0.6 in the DAS28 score\
and a SD of 1.0, the power analysis\
demonstrated that 95 patients would be a sufficient number to detect a clinically moderate difference between groups at a 5% significance level with at least 90% power. It was decided to include 107 patients to allow for the predicted 10% dropout. The primary outcome measure was change\
in the DAS28 over a 12‐month period\".[@CD001271-bbs2-0009]MethodsRandomised trialParticipants10134 patients (total group), all ages, 48% male 6 nurses 55 doctorsInterventions**Intervention:** nurse call management during out‐of‐hours **Control:** GP call management during out‐of‐hours\
**Detailed description of the intervention:**\
Compared 2 groups answering incoming phone calls for patients during out‐of‐hours\
[Nurse telephone consultation:]{.ul}\
In the intervention arm of the trial, all calls were passed straight to the nurse, except in the case of immediate referral to the ambulance service by the receptionist. The nurse then undertook a systematic assessment of the caller\'s problem and recommended an appropriate course of action. The nurse was aided by TAS (telephone advice system), a computer‐based primary care call management system. Triage nurses were able to complete calls without onward referral.\
Call management options for nurses included:\
Telephone advice:on home management of the problemto see the patient's own GP the next dayto attend the Accident and Emergency DepartmentReferral of the patient to the GP on duty:inviting the patient to attend the primary care centreadvising the caller that the GP would contact them by telephonecontacting the 999 ambulance service plus referral to the GP on dutyreferring to another agency (e.g. on call Community Psychiatric Nurse) plus referring to the GP on duty\
At the time of the study, triage nurses were seen to be acting as 'competent agents' of the GP. They had personal professional responsibility to ensure that they had been adequately prepared for the role and were accountable for their own actions. The GP could delegate care, but not accountability for that care.\
[Doctor telephone consultation:]{.ul}\
Incoming phone calls were answered by a receptionist, who passed the message to a doctor.\
Call management options for the GP were:\
Telephone advice:on home management of the problemto see the patient's own GP the next dayto bring the patient to be examined at the primary care centreto take the patient to the accident and emergency departmentExamination of the patient at home or in the primary care centre with:advice on home managementadvice to see the patient\'s own GP the next daytreatmentadmission to hospital\
**Supervision, oversight:**\
Nurses would refer calls to a GP if in doubt about how best to manage a situation, or would discuss the situation with the patient (in person at the centre or over the telephone). Before the end of every shift, triage nurses contacted the general practitioners on duty to report back on all calls they had managed. Formal, monthly professional supervision was provided by the trial project nurse.Outcomes**Patient outcomes:**\
Mortality\
**Resource utilisation:**\
Doctor workloadHospital referral and admissionEmergency department visitsDirect costsNotes**Country:** UK\
**Study period:** 3 to 7 days\
**Nurse role:** first contact care for patients with urgent problems out‐of‐hours\
**Nurse title:** not clear\
**Nurse educational background:** EQF level 6\
**Nurse years of experience:** Nurses were required to have a minimum of 5 years of post registration experience, including experience in primary health care.\
**Nurse additional training:** 6‐week educational programme to prepare nurses for a 3‐month probationary period of supervised telephone triage practice. The taught component covered clinical skills (management of adult and child health problems and related pharmacology); telephone consultation (including professional and medicolegal aspects, communication, and interpersonal skills at different phases of the telephone encounter); assessment and decision‐making skills in telephone triage; approaches to managing a variety of situations on the telephone including 'difficult' calls using scenarios; skills in using the TAS system; and patient perspectives. Programme contributors were largely drawn from clinical GPs involved with the trial and academic staff. The programme comprised approximately 40 hours in total, with 20 hours taught over 6 weeks and 20 hours of individual practical work and assessment.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskThe sequence process included a random component.\
\"The trial year was divided into 26 blocks of two weeks. Within each block, one of each pair of matching out of hours periods ‐ for example, Tuesday evenings ‐ was randomly allocated to receive the intervention, the other being allocated to the normal service, by means of a random number generator on a Hewlett Packard 21S pocket calculator\".Allocation concealment (selection bias)Low riskPatients and investigators enrolling patients could not foresee assignment. \"random number generator on a Hewlett Packard 21S pocket calculator\"Baseline characteristicsLow riskBaseline characteristics were reported and were similar for both groups. \"There were no substantial differences between the two trial groups\".Baseline outcome measurementUnclear riskPrimary outcomes were not assessed before the intervention.Blinding of participants and personnel (performance bias) All outcomesUnclear risk**Personnel (low risk):** \"The complete pattern of intervention periods was known in advance only to the lead investigators and the trial coordinator. Nurses providing the intervention knew their shifts only after the duty roster for general practitioners providing out of hours care had been fixed. General practitioners were therefore blind to the intervention at the point at which they were able to choose or swap duty periods\".\
**Patients (unclear risk):** no blinding; however it is unclear whether the outcome was influenced by lack of blinding of patientsBlinding of outcome assessment (detection bias) All outcomesUnclear riskNo informationIncomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80%Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationUnclear riskNo informationBias due to lack of powerLow riskSufficient power.\
\"\..., we calculated that 5455 patients would be required in each arm of the trial using the formula described by Jones et al\".[@CD001271-bbs2-0010]MethodsRandomised trialParticipants66 patients (total group), 16+ years, 12% male Unknown numbers of nurses and doctorsInterventions**Intervention:** patients allocated to nurse‐led care **Control:** patients allocated to doctor‐led care\
**Detailed description of the intervention:**\
Compared 2 groups delivering care to patients with chronic illnesses:\
Nurse clinic: nurses as the primary source of care for adults with chronic illnesses (i.e. hypertensive cardiovascular disease; arteriosclerotic heart disease; exogenous obesity; psychophysiological reactions; and arthritis)Control: medicine clinic\
**Supervision, oversight:** unknownOutcomes**Patient outcomes:**\
Health statusProvider preferenceCompliance with follow‐up attendance\
**Resource utilisation:**\
Direct costsNotes**Country:** USA\
**Study period:** 12 months\
**Nurse role:** ongoing primary care for patients with stable chronic disease\
**Nurse title:** not clear\
**Nurse educational background:** EQF level unknown\
**Nurse years of experience:** unknown\
**Nurse additional training:** unknown***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskNo informationAllocation concealment (selection bias)Unclear riskNo informationBaseline characteristicsLow riskBaseline characteristics were reported and were similar for both groups. \"There were no differences among the scores of the two groups on initial testing\".Baseline outcome measurementLow riskBaseline outcomes were reported and were similar for both groups.Blinding of participants and personnel (performance bias) All outcomesUnclear riskNot performed It is unclear whether the outcome was influenced by lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesUnclear riskNo informationIncomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80%Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationHigh riskPotential contamination represented by cross‐over of patients/clinicians between groups\
\"On 95% of these occasions, patients were seen by the nurse alone\".Bias due to lack of powerUnclear riskNo power calculation performed[@CD001271-bbs2-0011]MethodsRandomised trialParticipants1347 patients (total group), mean age 66 years, 69% male Unknown numbers of nurses and doctors in 21 practicesInterventions**Intervention:** patients with coronary heart disease allocated to nurse‐led follow‐up **Control:** patients with coronary heart disease allocated to doctor‐led follow‐up\
**Detailed description of the intervention:**\
Compared 3 different interventions for improving secondary preventive care of patients with coronary heart disease delivered at the level of general practice: audit and feedback; recall to a general practitioner; and recall to a nurse clinic\
*Audit and feedback (audit group) ‐* Practices were given summary audit results at a practice meeting (1 practice requested written material only). Results presented were numbers of patients with myocardial infarction, angina, and revascularisation; prevalence of identified coronary heart disease in the practice; and proportions of patients with "adequate assessment" and treatment with antiplatelet drugs, hypotensive agents, and lipid‐lowering drugs. Anonymised data from other practices in the study were given for comparison. Practices were asked to provide usual care and were given no further support during the trial.*Recall to general practitioner (GP recall group) ‐* Practices were given the same patient information as was given to the audit group but were also given the names of patients identified as having coronary heart disease. Guidelines for secondary prevention were discussed and agreed upon with practice doctors and provided ongoing support in setting up a register and recall system for regular review of patients with coronary heart disease by their general practitioner.*Recall to nurse clinic (nurse recall group) ‐* Practices were given the same patient information as was given to the GP recall group. The trial\'s nurse facilitator gave ongoing support to the practices in setting up a register and recall system for systematic review of patients with coronary heart disease in a nurse‐led clinic. After discussion of and agreement on guidelines for secondary prevention, practice doctors and nurses agreed on the clinical protocol, and nurses were taught how to implement it.\
**Supervision, oversight:** unknownOutcomes**Patient outcomes:**\
Cardiovascular risk factors\
**Process of care:**\
Adherence to guidelines\
**Resource utilisation:**\
PrescriptionsNotes**Country:** UK\
**Study period:** 18 months\
**Nurse role:** ongoing primary care for patients with coronary heart disease\
**Nurse title:** practice nurse\
**Nurse educational background:** EQF level unknown\
**Nurse years of experience:** unknown\
**Nurse additional training:** Nurses received education on how to implement the clinical protocol.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskNo informationAllocation concealment (selection bias)Unclear riskNo informationBaseline characteristicsLow riskBaseline characteristics were reported and were similar for both groups.\
\"Characteristics of the patients were similar in the three trial groups\".\
\"At baseline about 30% of patients were adequately assessed overall\".Baseline outcome measurementLow riskBaseline outcomes were reported and were similar for both groups. Effect sizes were adjusted for baseline.Blinding of participants and personnel (performance bias) All outcomesUnclear riskNot performed It is unclear whether the outcome was influenced by lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesUnclear riskNo informationIncomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80% \"Only patients were included who were alive and registered with the practice at follow up\".Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationLow riskAllocation was by practice.\
\"at the level of general practice\"Bias due to lack of powerUnclear riskNo power calculation performed[@CD001271-bbs2-0012]MethodsRandomised trialParticipants1316 patients (total group), mean age 44.5 years, 25.5% male 7 nurses 17 doctorsInterventions**Intervention:** patients allocated to nurse‐led care **Control:** patients allocated to doctor‐led care\
**Detailed description of the intervention:**\
Compared NPs and doctors as primary care providers within a conventional medical care framework at the same medical centre, where all other elements of care were identical. NPs provided all ambulatory primary care, including 24‐hour call, and made independent decisions for referrals to specialists and hospitalisations.\
NPs and doctors had the same authority to prescribe, consult, refer, and admit patients. Furthermore, they used the same pool of specialists, in‐patient units, and emergency departments.\
**Supervision, oversight:** MD supervision of NPs was consistent with New York State and hospital regulations: In New York State, NPs have a written agreement with an MD that states the MD will meet with the NP once or twice a year to review any practice issues, or to discuss certain cases. No on‐site or regular \"supervision\" is provided. In terms of hospitals in New York State, and an MD must sign off on every hospital admission within 24 hours of admission, but this still allows an NP with privileges to independently admit and care for a patient.Outcomes**Patient outcomes:**\
Health statusSatisfaction\
**Process of care:**\
Care given by providers\
**Resource utilisation:**\
Consultation rateUse of other services ‐ hospital admissions, emergency department visits, specialty visitsNotes**Country:** USA\
**Study period:** 2 years\
**Nurse role:** first contact and ongoing primary care\
**Nurse title:** nurse practitioners\
**Nurse educational background:** EQF level 7\
**Nurse years of experience:** average of 8 to 10 years of experience for NPs in the study\
**Nurse additional training:** Additional training was received from MDs in hospital‐based activities, including how to admit and bring necessary resources to the patient (specialists, radiology, lab work, etc); training was also provided in interpreting tests and conducting emergency department evaluations.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskNo method of randomisation was clearly reported.\
\"Those who provided informed consent were randomly and blindly assigned to either the nurse practitioner or 1 of the physician practices. Different assignment ratios were used during the recruitment period. Initially the ratio was 2:1, with more patients assigned to the nurse practitioner practice, because it opened after the physician practices and was able to accept more new patients. Subsequently, the ratio was changed to 1:1 as the nurse practitioner practice's patient panel increased\".Allocation concealment (selection bias)Unclear riskMethod of concealment was not described in sufficient detail.Baseline characteristicsLow riskMost baseline characteristics were reported and were similar for both groups.\
\"With regard to demographic characteristics, groups are similar with exception: Significant more patients Medicaid enrolled in physician group (95.7%) versus 87.4% nurse group; p = 0.004\".Baseline outcome measurementLow riskBaseline outcomes were reported and were similar for both groups.Blinding of participants and personnel (performance bias) All outcomesUnclear riskIt is unclear whether the outcome was influenced by lack of blinding of patients and care providers.\
\"Those who provided informed consent were randomly and blindly assigned to either the nurse practitioner or 1 of the physician practices\". \"Patients were told which provider group they were assigned to after randomisation, and the type of provider could not be masked during the course of care\".Blinding of outcome assessment (detection bias) All outcomesUnclear riskNo information.Incomplete outcome data (attrition bias) All outcomesHigh riskFollow‐up of patients \< 80% (Figure 1, page 64)\
1316 were enrolled, 1040 completed 6‐month interview (79%). \"Only 406 of the original eligible patients are included, as these patients were the only ones who still received care from original provider\". \"The number varied per measure from 77 to 119\".\
77/145 = 53.1%; 119/145 = 82.06%Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationHigh riskContamination could have occurred.\
\"The 159 patients (12.1%) who, after the first visit, either went to a clinic other than the one assigned or to multiple primary care clinics were maintained in the initially assigned group for the analyses, consistent with an intent‐to‐treat analysis. All analyses were repeated without these 159 patients, and the results were the same\".\
Art. Lenz et al: \"The present analysis is limited to the 406 patients who received primary care only from the assigned practice and made at least one follow‐up visit to that practice during the 2 years following the initial visit. This subsample was the only one that received the treatment as assigned and in which the effect of the treatment could be isolated\".Bias due to lack of powerLow riskSufficient power[@CD001271-bbs2-0013]MethodsRandomised trialParticipants181 patients (total group), 91 intervention group, 90 control group; mean age in intervention group 60.2 (11.3), in control group 57.3 (12.2); 26.5% male in intervention group, 25.7% male in control group\
9 nurses\
10 doctors (rheumatologists)Interventions**Intervention:** RA patients allocated to nurse‐led care\
**Control:** RA patients allocated to rheumatologist care\
**Detailed description of the intervention:**\
Compared 2 groups providing care to patients with a positive diagnosis of RA\
Nurse‐led care: included allocated 30‐minute time slots in which the nurse took history, performed physical examination, provided pain control, prescribed or recommended medication and dosage changes, administered intra‐articular or intramuscular steroid injections, provided patient education and psychosocial support, and ordered blood tests or x‐rays. Referrals for ward admission, to the rheumatologist or to other healthcare professionals, were carried out as appropriate.Rheumatologist care: The usual RLC is similar to the above, except that it usually involves an allocated 15‐minute time slot.\
**Supervision, oversight:** Rheumatology nurse‐led clinics were autonomous but were conducted alongside rheumatologist‐led clinics; therefore, a rheumatologist was available on‐site and could be consulted.Outcomes**Patient outcomes:**\
DAS28PainFatigueDuration of morning stiffnessQuality of lifeDisabilityHospital anxietyDepressionArthritis self‐efficacySatisfaction\
**Resource utilisation:**\
**Costs:** EQ5D, costs applied to units of resource useNotes**Country:** UK\
**Study period:** 4 years\
**Nurse role:** ongoing care for patients with rheumatological arthritis\
**Nurse title**: clinical nurse specialist\
**Nurse educational background:** EQF level 7\
**Nurse years of experience:** The nurse had a median experience of 10 years in their current post and had experience in running nurse‐led clinics.\
**Nurse additional training:** none***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskThe sequence process included a random component.\
\"Randomisation was on a 1 : 1 basis to either NLC (experimental group) or rheumatologist‐led care (RLC) (control group), by random permuted blocks, using the stratification factors, centre and DAS28 (low disease activity DAS28 ≤ 3.2, or moderate to high disease activity DAS28 \> 3.2)\".Allocation concealment (selection bias)Low riskPatients or investigators enrolling patients could not foresee assignments, because a random permuted block method was used.Baseline characteristicsLow riskCharacteristics of patients were similar in both groups, except DMARD. In the analyses, trial authors corrected for DMARD.\
\"The demographics and baseline characteristics of patients under NLC (n = 91) were comparable to those under RLC (n = 90) except in the proportion of patients receiving biological disease‐modifying antirheumatic drugs (DMARD)\".\
\"The baseline difference in the proportion of patients receiving biological DMARD was a result of chance (not systematic). In the follow‐up period, the proportion of patients receiving biological agents in NLC remained more or less constant while that in RLC doubled. Assuming that change onto biological agents would significantly improve DAS28, this was likely to favour RLC. Predictably, additional adjustment for baseline biological agents increased the effects on NLC\".Baseline outcome measurementLow riskPrimary outcomes were assessed before the intervention.Blinding of participants and personnel (performance bias) All outcomesUnclear riskIt is unclear whether the outcome was influenced by lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesLow riskOutcome assessor was blind.\
\"The independent assessors, performing the joint counts for DAS28, were masked\".Incomplete outcome data (attrition bias) All outcomesUnclear riskFollow‐up of patients \< 80%\
However, intention‐to‐treat and per‐protocol analyses were performed. Differences in outcomes were reported.\
\"Of the 622 patients who were assessed for eligibility, 181 were eventually randomly assigned and 133 (73.5%) had complete DAS28 data for all the five visits (PP analysis)\".Selective reporting (reporting bias)Low riskThe protocol was available.ContaminationLow riskOne patient crossed over. It seems that the patient crossing over was registered; therefore no further contamination took place.Bias due to lack of powerLow riskSufficient power\
\"Allowing for a 10% participant dropout rate, a total sample size of 180 participants (90 per treatment arm) was needed on the basis of a repeated‐measures analysis of between‐group differences averaged over four equidistant follow‐up time points given 90% power and one‐sided statistical testing with 2.5% significance level (with anticipated SD of 1.5, intraclass correlation coefficient of 0.5)\".[@CD001271-bbs2-0014]MethodsRandomised trialParticipants812 patients (total group), gender unknown\
4 nurses\
4 medical officersInterventions**Intervention:** patients with HIV allocated to nurses\
**Control:** patients with HIV allocated to medical officers\
**Detailed description of the intervention:**\
Compared nurse‐ vs doctor‐monitored HIV care. All patients were managed under South African National Guidelines for HIV treatment and were given standard ART regimens.\
**Supervision, oversight:** unknownOutcomes**Patient outcomes:**\
MortalityFailure (virological failure, toxicity failure, study losses)SatisfactionNotes**Country:** South Africa\
**Time period:** 47 months\
**Nurse role:** primary healthcare nurses\
**Nurse type:** primary healthcare nurses\
**Nurse educational background:** EQF level unknown\
**Nurse years of experience:** unknown\
**Nurse additional training:** unknown***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskThe sequence process included a random component.\
\"Participants were randomly assigned in a ratio of 1:1 within sites. Randomisation lists were generated centrally with a stratified permuted block randomisation (with blocks of six). The strata corresponded to the different study sites\".Allocation concealment (selection bias)Low riskPatients and investigators enrolling patients could not foresee assignment. \"The allocation codes for a particular site were sealed in sequentially numbered envelopes, reflecting their order on the randomisation list, and distributed to the site. At randomisation, the site pharmacist unsealed the sequential envelope to reveal the randomisation code and participant randomisation number\".Baseline characteristicsLow riskCharacteristics of patients were similar in both groups.Baseline outcome measurementLow riskBaseline outcome measurement was not relevant.\
\"The primary study outcome was a composite endpoint of possible treatment‐limiting events that could occur on first‐line ART\".Blinding of participants and personnel (performance bias) All outcomesUnclear riskNot performed\
It is unclear whether the outcome was influenced by lack of blinding of patients and care providers.\
\"Neither the participant nor those analysing the data were masked to the assignment\".Blinding of outcome assessment (detection bias) All outcomesUnclear riskNot performed\
It is unclear whether the outcome was influenced by lack of blinding of the outcome assessment.\
\"Neither the participant nor those analysing the data were masked to the assignment\".Incomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80% \"917 patients were assessed for eligibility, 105 excluded. Of excluded patients, 16 refused to participate and 89 did not meet inclusion criteria.\
There were 10 lost to follow‐up in the nurse group and 14 lost to follow‐up in the doctor group\".\
Trial authors did not mention the reason for loss to follow‐up,\
but all patients were included in primary outcome analysis.Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationLow riskIt is unlikely that both groups were contaminated.\
\"To limit contamination between randomised groups, work activity and monitoring schedules were separated with routine visits scheduled on different days of the week, although at least one clinician was available to undertake unscheduled visits in the other group of the study\".Bias due to lack of powerLow riskSufficient power\
\"The sample size was calculated based on an 18‐month accrual and 96 weeks' follow‐up with 80% power and α of 0·05. Because we did not record significant household clustering, enrolment was able to be discontinued after 812 patients with no compromise of pre‐established study power\".[@CD001271-bbs2-0015]MethodsRandomised trialParticipants1815 patients (total group), mean age 27.5 years, 40% male 5 nurses 19 doctorsInterventions**Intervention:** patients allocated to nurse **Control:** patients allocated to doctor\
**Detailed description of the intervention:**\
Compared acceptability and effectiveness of a practice‐based minor illness service led by nurses versus routine care offered by general practitioners. Nurses managed patient care and took the history, performed a physical examination, offered advice and treatment, issued prescriptions (which required a doctor\'s signature), and referred the patient to the doctor when appropriate.\
**Supervision, oversight:** Patients seen by a nurse were referred to a general practitioner when appropriate.Outcomes**Patient outcomes:**\
Health statusSatisfactionProvider preference\
**Process of care:**\
Provision of information\
**Resource utilisation:**\
Length of consultationReturn visitsPrescriptionsEmergency department visitsUse of out‐of‐hour servicesNotes**Country:** UK\
**Study period:** 2 weeks\
**Nurse role:** first contact care for patients with urgent problems\
**Nurse title:** practice nurse\
**Nurse educational background:** EQF level unknown\
**Nurse years of experience:** average of 8.4 (3.8) years of experience in practice nursing\
**Nurse additional training:** 3‐month academically accredited degree level course on managing minor illnesses. Nurses attended one half‐day a week of formal group teaching by a nurse practitioner and were taught twice a week by general practitioners during routine surgeries in the practice where the nurses worked.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskSequence was generated by non‐resealable opaque envelopes.\
\"Allocation to being seen by a doctor or nurse was determined using random permuted blocks of four with sequentially numbered, non‐resealable opaque envelopes\".Allocation concealment (selection bias)Low riskAllocation was concealed by sequentially numbered, non‐resealable opaque envelopes.\
\"Allocation to being seen by a doctor or nurse was determined using random permuted blocks of four with sequentially numbered, non‐resealable opaque envelopes\".Baseline characteristicsLow riskBaseline characteristics were reported and were similar for both groups.\
\"The two groups of patients were comparable in terms of age, sex, the number who usually preferred to see a female doctor rather than a male, and their reported rates of consultation in the previous 12 months (table 1)\".\
Baseline outcome measures were not relevant.Baseline outcome measurementUnclear riskPrimary outcomes were not assessed before the intervention.Blinding of participants and personnel (performance bias) All outcomesUnclear riskIt is unclear whether the outcome was influenced by lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesUnclear riskNo informationIncomplete outcome data (attrition bias) All outcomesLow riskFor most outcomes, follow‐up was \> 80%.\
Follow‐up for satisfaction questionnaire was \> 75%, for mailed questionnaire 76%.Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationUnclear riskNo informationBias due to lack of powerLow riskSufficient power\
\"It was calculated that 1060 valid responses would be sufficient to detect an effect size of 0.2 SD at the 95% confidence level with a power of 90% using two tailed tests\".[@CD001271-bbs2-0016]MethodsRandomised trialParticipants4325 patients (total group), all ages, 42.5% male 2 nurses 2 doctorsInterventions**Intervention:** families allocated to nurse **Control:** families allocated to doctor\
**Detailed description of the intervention:** not available\
**Supervision, oversight:** unknownOutcomes**Patient outcomes:**\
Health statusSatisfactionProvider preference\
**Process of care:**\
Standards of care\
**Resource utilisation:**\
Direct costsNotes**Country:** Canada\
**Study period:** 12 months\
**Nurse role:** first contact and ongoing primary care\
**Nurse title:** nurse practitioners\
**Nurse educational background:** EQF level unknown\
**Nurse years of experience:** unknown\
**Nurse additional training:** unknown***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskNo informationAllocation concealment (selection bias)Unclear riskMethod of concealment was not described in sufficient detail.\
\"Because a case load half that of a family physician\'s was considered manageable for nurse practitioner, the eligible families were stratified by practice of origin, and randomly allocated in a ration of 2:1. They formed a randomized conventional group, assigned to continuing primary clinical services from a family physician and a conventional nurse, and a randomized nurse‐practitioner group, whose first‐contact primary clinical services were to be provided by a nurse practitioner\".Baseline characteristicsLow riskBaseline characteristics were reported and were similar for both groups.\
\"As determined in the 1971 household survey, the patients in the conventional and nurse‐practitioner groups had highly similar values for physical function, ability to carry out usual daily activities and freedom from bed disability the baseline health status of the two groups of patients showed only minor differences that were not statistically significant (at an alpha level of 0.05)\".\
Figure 1: Baseline outcome variable was measured.\
\"Physical status of patients in surveys during baseline and comparison periods\"Baseline outcome measurementLow riskBaseline outcomes were reported and were similar for both groups.Blinding of participants and personnel (performance bias) All outcomesUnclear riskIt is unclear whether the outcome was influenced by lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesUnclear riskNo informationIncomplete outcome data (attrition bias) All outcomesLow riskFollow‐up of patients \> 80%\
\"The resulting cohort that was successfully interviewed in both years included 817 patients, with 296 in the experimental group and 21 in the conventional control group. The referral rates in the surveys were 11% in 1971 and 5% in 1972\".Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationHigh riskIt is likely that both groups were contaminated, because randomisation was by families within a practice.\
Not reported whether they protect against contaminationBias due to lack of powerUnclear riskNo power calculation performed[@CD001271-bbs2-0017]MethodsRandomised trialParticipants1316 patients (total group), all ages, 42% male 20 nurses Unknown number of doctorsInterventions**Intervention:** patients allocated to nurse **Control:** patients allocated to doctor\
**Detailed description of the intervention:**\
Compared care given by general practitioners and nurse practitioners for patients requesting a same‐day appointment\
**Supervision, oversight:** unknownOutcomes**Patient outcomes:**\
Health statusSatisfactionCompliance with follow‐up attendanceEnablement\
**Process of care:**\
Examinations\
**Resource utilisation:**\
Length of consultationReturn visitsPrescriptionsInvestigationsUse of other services ‐ hospital referralDirect costsNotes**Country:** UK\
**Study period:** 2 weeks\
**Nurse role:** first contact care for patients with urgent problems\
**Nurse title:** nurse practitioners\
**Nurse educational background:** EQF levels 5, 6, and 7\
**Nurse years of experience:** The median length of time nurses had been qualified as nurse practitioners was 3 (range 1 to 5) years, and the median time as registered nurses was 22 (9 to 35) years. Each nurse practitioner had been seeing patients as first point of contact for at least 2 years.\
**Nurse additional training:** unknown***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskThe sequence process included a random component.\
\"In each practice, experimental sessions were booked when both the nurse practitioner and a general practitioner had appointments available for patients who asked to be seen on the same day. Patients were eligible for entry to the study if they requested an appointment the same day and were able to come to the experimental session. If these conditions were satisfied, the receptionist then asked patients whether they would agree to be randomised to see either a\[n\] NP or a GP. A method of coded block randomisation was developed which meant that neither the receptionist nor the patient could determine the group to which a patient had been allocated at the time of booking. The coded blocks were generated from random number tables. The randomisation code was broken by one of the researchers at the start of each experimental session, at which point it became apparent which patient would see which practitioner. Randomization continued until a minimum of 60 patients in each practice had been allocated to the clinician groups\".Allocation concealment (selection bias)Low riskPatients and investigators enrolling patients could not foresee assignment.\
\"Method of coded block randomisation was developed which meant that neither the receptionist nor the patient could determine the group to which a patient had been allocated at the time of booking. The coded blocks were generated from random number tables. The randomisation code was broken by one of the researchers at the start of each experimental session, at which point it became apparent which patient would see which practitioner\".Baseline characteristicsLow riskBaseline characteristics were reported and were similar for both groups.Baseline outcome measurementUnclear riskNo baseline outcome measurement was performed.Blinding of participants and personnel (performance bias) All outcomesUnclear riskGPs and NPs were not blinded. Patients were not blinded. It is unclear whether the outcome was influenced by lack of blinding of patients and care providers.Blinding of outcome assessment (detection bias) All outcomesUnclear riskNo informationIncomplete outcome data (attrition bias) All outcomesHigh riskFollow‐up of patients \< 80%Selective reporting (reporting bias)Unclear riskThe protocol was not available.ContaminationUnclear riskNo information\
Allocation on patient levelBias due to lack of powerUnclear riskNo power calculation performed[@CD001271-bbs2-0018]MethodsRandomised trialParticipants1626 patients (1626 randomised, 701 trial population); 64% male\
6 practice nurses\
25 GPsInterventions**Intervention:** patients at cardiovascular risk allocated to practice nurses\
**Control:** patients at cardiovascular risk allocated to GPs\
**Detailed description of the intervention:**\
Compared 2 groups following the Dutch guideline for cardiovascular risk management. Patients in the practice nurse group had a consultation with the practice nurse for assessment of other risk factors, and a 3‐monthly monitoring schedule was set up for patients but was adjusted individually according to the risk profile, (co)morbidity, and patient preferences. Patients could be referred to other professionals, such as a dietician.\
Substitution involved the following tasks:\
Risk assessmentInterventions needed: advice on lifestyle, referral to dietician or other professional, adjustment of medical therapy\
**Supervision, oversight:** unknownOutcomes**Patient outcomes:**\
Blood pressureCholesterolBMISmokingSatisfactionPatient adherence to medical treatment after 1 year of follow‐upPatient lifestyle after 1 year of follow‐up\
**Process of care:**\
Lifestyle and medical interventionsAsking about the use of medication\
**Resource use:**\
Referral to professionalsVisiting a cardiovascular specialistAdmission into hospital because of CVDNotes**Country:** Netherlands\
**Study period:** not clear (1 measurement at 1 year with an unclear total period of the study)\
**Nurse role:** health education: secondary prevention consultation for patients with cardiovascular disease\
**Nurse title:** practice nurse\
**Nurse educational background:** EQF level 5\
**Nurse years of experience:** unknown\
**Nurse additional training:** All nurses received a 1‐day course on motivational interviewing and shared decision‐making.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskAllocation concealment (selection bias)Low riskBaseline characteristicsLow riskBaseline outcome measurementLow riskBaseline outcomes were reported.\
\"The marginal mean is controlled for health care centre, baseline risk factors, and other confounders\".Blinding of participants and personnel (performance bias) All outcomesLow riskIncomplete outcome data (attrition bias) All outcomesLow riskContaminationHigh riskBias due to lack of powerLow risk[^9]

Characteristics of excluded studies \[ordered by study ID\] {#CD001271-sec2-0021}
===========================================================

StudyReason for exclusion[@CD001271-bbs2-0019]CBA design[@CD001271-bbs2-0020]non‐randomised study[@CD001271-bbs2-0021]CBA design[@CD001271-bbs2-0022]Setting: mixed primary healthcare and hospital care[@CD001271-bbs2-0023]non‐randomised study[@CD001271-bbs2-0024]Setting: mixed primary care and hospital medicine[@CD001271-bbs2-0025]Aimed at mental health problems (alcohol abuse and addiction)[@CD001271-bbs2-0026]CBA design[@CD001271-bbs2-0027]non‐randomised study[^10]

Characteristics of studies awaiting assessment \[ordered by study ID\] {#CD001271-sec2-0022}
======================================================================

[@CD001271-bbs2-0028]MethodsCluster randomised trialParticipants40 patients in intervention group. Mean age: 40 (8.4). 65 patients in control group. Mean age: 42 (8,5) 80% male in intervention group, 74% male in control groupInterventions**Intervention:** patients allocated to nurse‐initiated antiviral therapy **Control:** patients allocated to doctor‐initiated antiviral therapy\
**Detailed description of the intervention:**\
Patients without contraindications to nurse‐led therapy were offered immediate antiviral therapy administered by their Blood Borne Virus Team nurse in their outreach clinic without physician assessment. Patients who did not fulfil the safety criteria for the 'nurse led' treatment arm were referred to one of the specialist addiction units for treatment, that is, were managed according to current standard of care.\
**Supervision, oversight:** unknownOutcomesProportion of participants initiating treatment during follow‐upAdherenceSide effects of the treatmentAdverse eventsNotes**Country:** UK\
**Study period:** 24‐48 weeks\
**Nurse role:** administration of antiviral therapy\
**Nurse title:** Blood Borne Virus nurses\
**Nurse educational background:** unknown\
**Nurse years of experience:** unknown\
**Nurse additional training:** unknown

This review update was led by AvV and ML. ML, MvdB, NW, and AvV assessed studies for inclusion. ML, MvdB, NW, and AvV participated in data extraction and contributed to data analysis. AvV undertook the meta‐analysis with assistance from the other review authors. ML, MvdB, and AvV drafted the review, drawing on contributions from several review authors, and all review authors commented on this draft.
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This is an update of the review "Substitution of doctors by nurses in primary care", which was first published in 2005 for the Cochrane Library ([@CD001271-bbs2-0079]).

[^1]: Editorial Group: Cochrane Effective Practice and Organisation of Care Group.

[^2]: ^a^ Authors reported no effect size or reported effect sizes in graphs (no exact effect sizes extracted).

    ^b^ No p‐value reported.

    ASES: Standardized Shoulder Assessment Form.

    BMI: body mass index.

    CI: confidence interval.

    CRP: C‐reactive protein.

    DAS28: disease activity score 28.

    ESR: erythrocyte sedimentation rate.

    GP: general practitioner.

    HAD: Hospital and Anxiety Depression Scale.

    HAQ: Health Assessment Questionnaire.

    HDL: high‐density lipoprotein.

    HR: heart rate.

    ITT: intention‐to‐treat.

    LDL: low‐density lipoprotein.

    MD: mean difference.

    NP: nurse practitioner.

    RAQoL: Rheumatoid Arthritis Quality of Life Questionnaire.

    VAS: visual analogue scale.

    \*there may be additional data in the [@CD001271-bbs2-0001] articles that have not been extracted

[^3]: ^a^no p‐value reported

    ^b^ authors reported no effect size or reported effect sizes in graphs (no exact effect sizes extracted)

    CI: confidence interval.

    GP: general practitioner.

    LSQ: Leeds Satisfaction Questionnaire.

    MD: mean difference.

    NP: nurse practitioner.

    NRS: Numeric Rating Scale

    \*there may be additional data in the [@CD001271-bbs2-0001] articles that have not been extracted

[^4]: ^a^Trial authors reported only the direction of the outcome; it is unknown if the difference is statistically significant.

    ^b^Trial authors reported no effect size or reported effect sizes on graphs (no exact effect sizes extracted).

    CI: confidence interval.

    GP: general practitioner.

    MD: mean difference.

[^5]: ^a^No P value reported.

    ^b^Trial authors reported only the direction of the outcome; it remains unknown whether the difference is statistically significant.

    ^c^Trial authors reported no effect size or reported effect sizes in graphs (no exact effect sizes extracted).

    CI: confidence interval.

    GP: general practitioner.

    MD: mean difference.

    RR: risk ratio.

    \*there may be additional data in the [@CD001271-bbs2-0001] articles that have not been extracted

[^6]: ^a^Trial authors reported no effect size or reported effect sizes in graphs (no exact effect sizes extracted).

    ^b^No P value reported.

    ^c^Trial authors reported only the direction of the outcome; it remains unknown whether the difference is statistically significant.

    ^d^Too many numbers to report.

    CI: confidence interval.

    CT: computed tomography.

    CVD: cardiovascular disease.

    GP: general practitioner.

    MRI: magnetic resonance imaging.

    NP: nurse practitioner.

    RR: risk ratio.

    \*there may be additional data in the [@CD001271-bbs2-0001] articles that have not been extracted

[^7]: ^a^Spitzer reported an overall reduction in practice costs following the introduction of nurse practitioners, but this finding was based on observational before‐and‐after data. Data obtained from the related randomised controlled trial (reported above) did not support this finding.

    A&E: accident and emergency.

    CI: confidence interval.

    DEXA: dual energy x‐ray absorptiometry.

    GP: general practitioner.

    \*there may be additional data in the [@CD001271-bbs2-0001] articles that have not been extracted

[^8]: APRN: advanced practice registered nurse.

[^9]: Outcomes: If we noted a difference in incomplete outcome data or baseline outcome measurement for different outcomes in the studies, we described these as support for judgement.

    ART: antiretroviral therapy.

    BP: blood pressure.

    CCDS: computerised clinical decision support.

    Chol: cholesterol.

    CVD: cardiovascular disease.

    DAS28: disease activity score 28.

    DMARD: disease‐modifying antirheumatic drug.

    EQ‐5D: EuroQoL Group Quality of Life Questionnaire.

    EQF: European Qualifications Framework.

    GI: gastrointestinal.

    GNP: geriatric nurse practitioner.

    GORD: gastroesophageal reflux disease.

    GP: general practitioner.

    HbA1c: glycated haemoglobin.

    Hdl: high‐density lipoprotein.

    HIV: human immunodeficiency virus.

    HRQOL: health‐related quality of life.

    NLC: nurse‐led care.

    NP: nurse practitioner.

    NUD: non‐ulcer dyspepsia.

    PN: practical nurse.

    RA: rheumatoid arthritis.

    RLC: rheumatologist‐led care.

    SF‐12: Short Form questionnaire.

    T2DM: type 2 diabetes mellitus.

[^10]: CBA: controlled before‐after study.
